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Abstract 
 
Although violence perpetrated by people with a mental disorder is rare, it is nevertheless 
problematic.  There is therefore a need to develop a better understanding of the underlying 
risk factors for violence in psychiatric populations.  This systematic review aimed at 
exploring and synthesising the recent evidence for the association between one such factor 
(positive psychotic symptoms) and violence in people with schizophrenia.  Research 
published between 2000-2010 which reported on the association between positive 
symptoms and violence in people with schizophrenia was searched and selected on the 
basis of pre-defined inclusion/exclusion criteria.  This produced eleven studies which were 
deemed suitable for inclusion in the review.  These studies suggested overall that there is an 
association between the presence of positive symptoms and violence in people with 
schizophrenia.  However, when odds ratios (ORs) were reported, they were often small and 
likely of little clinical significance.  Furthermore, there were limitations on the interpretation 
of the findings based on the variation in design, methodology, definition and measurement 
of variables, statistical analysis and overall methodological quality.  This highlights the need 
for further and more rigorous research in this area before any firm conclusions can be 
drawn.        
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Introduction 
 
Violence and Mental Illness 
 
The issue of violence amongst people with a mental illness is highly contentious and has 
invited much attention over the years from health professionals.  Despite unhelpful 
portrayals of mental illness and violence in the media, which can reinforce a common public 
misperception that people with mental health problems are dangerous and unpredictable 
(Allen & Nairn, 1997), the reality is quite different.  In their review of the evidence for 
violence in people with schizophrenia, Walsh, Buchanan and Fahy (2002) reported that 
although this diagnosis was associated with a marginally increased risk of violence 
compared to a member of the general public, the proportion of violence in society 
apportionable to this group was in fact very small.  
 
A recent study acknowledged that while the (small) level of association between these two 
variables is widely reported, less is actually known about why this might be the case in 
people with a mental illness (Fazel, Långström, Hjern, Grann, & Lichtenstein, 2009).  
Speculation on independent risk variables for future violence has been a common theme in 
the literature in this area.  Elbogen and Johnson (2009) state that having a severe mental 
illness is not in itself enough to predict, or cause, violence.  They reported that the incidence 
of violence amongst people with a severe mental illness was only greater when there was 
co-morbid substance abuse/dependence.  Furthermore, historical, clinical, dispositional and 
contextual factors rather than having a mental illness per se have reportedly been predictive 
of violence (e.g., Chow & Ng, 2007).   
 
Violence and the Role of Positive Symptoms 
 
Recently research has begun to look in more detail at the clinical correlates of mental illness 
– particularly psychotic illnesses – to discover what these can tell us about future violence 
risk.  It would appear that ‘positive symptoms’ may be linked to violence in this clinical 
population, although the evidence is somewhat mixed.  Positive symptoms describe those 
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which occur in addition to what is considered typical in ‘normal’ functioning.  These include 
hallucinations, delusions and thought disorder. 
 
Research has looked at whether hallucinations – in particular command hallucinations – can 
explain the observed link between mental illness and violence.  Much of the evidence 
reported is conflicting, and there is a wide variation of methodology used to investigate this 
issue.  In one such example, after asking psychiatric patients to complete questionnaires, 
logistic regression analyses on the data suggested command hallucinations to harm others 
led to a two-fold increase in violence, even after controlling for potential confounding 
variables including substance misuse (McNiel, Eisner, & Binder, 2000).  Conversely, Rogers, 
Watt, Gray, MacCulloch and Gournay (2002) found evidence to suggest that command 
hallucinations with a violent content were not related to violence within a medium secure 
inpatient unit.  Notably there were distinct differences in methodology between these two 
studies, including the methods used to measure the variables of interest and participant 
characteristics.  In a review on this subject, it was noted that there is disparity in opinion 
amongst researchers as to whether or not command hallucinations influence dangerous 
behaviour, perhaps reflective of the wide variation in methodological rigour and definition 
of outcomes.  However, what has emerged is that command hallucinations are neither 
necessary nor sufficient for violent action, and many variables are thought to mediate this 
relationship (Braham, Trower, & Birchwood, 2004).          
 
Following on from these observations, in an attempt to better understand the relationship 
between command hallucinations and violence, factors of compliance and harmful 
command hallucinations have been investigated.  In a review on this issue, the authors 
concluded that much was still to be learned about what might mediate the relationship 
between command hallucinations and violence towards others.  However, they highlighted 
the importance of investigating both the content of, and beliefs about, the hallucinations 
when assessing risk for future violence (Barrowcliff & Haddock, 2006).  
 
Another positive symptom discussed in the literature is delusions.  As has been the case for 
studies reporting a link between violence and hallucinations, the literature on delusions has 
yielded mixed findings.  Some evidence has been reported which suggests there is a 
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relationship between delusions (particularly persecutory delusions) and violent behaviour, 
with their presence helping to predict an increased risk of violence (e.g., Chow & Ng, 2007).  
Yet others still have drawn the conclusion that delusions are not associated with an 
increased risk of violent behaviour.  For example, using data from the McArthur Violence 
Risk Assessment Study, Appelbaum and colleagues (2000) argued delusions generally did 
not increase the risk for violence overall, although they acknowledged that they may play a 
role on a case-by-case basis.  They postulated that the disparity in the literature could be 
attributed to methodological limitations that cause other variables that increase the risk for 
violence being misclassified as delusions (Appelbaum, Robbins, & Monahan, 2000). 
 
Link and Stueve (1994) have proposed that a particular set of positive symptoms 
experienced in people with psychotic disorders – so called “threat/control-override” (TCO) 
symptoms – can help to explain the increased risk of violence in this population.  These 
explain a group of symptoms that lead an individual with mental illness to feel threatened or 
interfere in such a way that they override the individual’s resistance to violence.  They argue 
that other psychotic symptoms can only be linked to violence in so much as they are 
associated with TCO symptoms.  Although some support has been found for this theory 
(e.g., Swanson, Borum, Swartz, & Monahan, 1996), others have suggested that TCO 
symptoms do not predict a higher risk of violence (Appelbaum et al., 2000).   
 
Violence in Schizophrenia  
 
Clearly there is much debate in the literature about whether positive symptoms in mental 
illness are linked to violence, and why this might be the case.  Although there are many 
methodological issues that may offer some explanations for these disparities, one emergent 
suggestion is that the link between positive psychotic symptoms and violence may differ 
between diagnostic groups (Hodgins, Hiscoke, & Freese, 2003).  Consequently, some 
researchers have recruited participants with the same primary diagnosis to control for this, 
and people with schizophrenia are the most commonly used in this research.  This 
diagnostic group has attracted the attention of researchers for several reasons, but perhaps 
importantly because this diagnosis is often linked to pessimistic outcomes in the literature, 
and the diagnostic criteria emphasise the chronicity of the condition (World Health 
Page | 14  
 
Organisation, 2007).  Furthermore, in certain settings this diagnostic group has proven to be 
particularly pertinent.  For example, amongst the forensic population, often the most 
common diagnostic group is schizophrenia (e.g., Taylor et al., 1998). 
 
Looking at violence in people with schizophrenia, there is still paucity in agreement in the 
research about the role of positive symptoms.  Although some reviews in this area have 
begun to look into this, it is still a surprisingly neglected area.  Walsh et al. (2002) have 
completed a review of the epidemiological evidence for the relationship between violence 
and schizophrenia, which included some consideration of the likely risk factors that may 
mediate this association.  However, they were selective in the range of literature that they 
included.  Furthermore, Bjørkly (2002a; 2002b) has reviewed the evidence on the 
association between delusions and hallucinations and violence, although this included 
diagnostic groups other than schizophrenia, which may limit the generalisability of the 
findings.   Therefore, given the reasons for brining the focus of research to people with 
schizophrenia and violence, a review in this area would be helpful to consolidate what we 
know and where there are gaps in the literature, so as to direct future research.  This was 
the purpose of this systematic review.  Although a systematic review of this nature has not 
been done to the author’s knowledge, given the previous reviews described above have 
covered the literature up until the turn of the century, the current review has looked at the 
literature from 2000 to 2010. 
 
Aims 
 
The aims of this systematic review were as follows:  
• To explore the evidence for an association between the presence of positive 
symptoms and violence in people with schizophrenia. 
• To synthesise and discuss the key research findings in this area from 2000 to 2010 
and consider what this might this tell us about their relationship/underlying 
mechanisms. 
• To consider the quality of research published between 2000-2010 in which the 
association between positive symptoms and violence risk in people with 
schizophrenia has been reported.  
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Methodology 
 
Search Strategy 
 
A systematic search was conducted of electronic databases.  Some were accessed via OVID 
online (Medline, Embase, PsychInfo and EMB Review databases).  In addition, searches were 
carried out using CINAHL and Web of Science databases.  The following terms were entered 
as text words during the search, and combined with ‘OR’: 
• Schizophreni*; psychotic disorder; psychos*; severe mental illness*; severe mental 
disorder* 
• Violence; violent behavio*; dangerous behavio* 
• Positive symptom*; hallucination*; delusion*; thought disorder*; threat control override 
 
Where possible, relevant search terms were used for Medline, Embase, PsychInfo and EMB 
Review databases.  These searches were then combined with the AND tool, in order to 
produce a final output of studies, which would capture those looking at the role of positive 
symptoms in violence perpetrated by people with a schizophrenia diagnosis.  Searches were 
limited to English language, human subjects, and to studies published between January 
2000 – December 2010.  Finally, duplicate studies were removed. 
 
Hand searches were conducted of two leading journals in the area of interest (Schizophrenia 
Bulletin and the Journal of Forensic Psychology & Psychiatry).  Hand searches were also 
carried out on reference lists of selected papers, and on review papers on related topics.  
 
Inclusion and Exclusion Criteria 
 
The abstract and/or title of each paper identified from the search were screened for 
suitability according to the inclusion and exclusion criteria.  The full paper was obtained for 
situations when suitability could not be determined by review of the title and abstract 
alone.  The inclusion criteria were as follows: 
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• Studies that report on the relationship between violence and positive symptoms 
(collectively or individually) of schizophrenia. 
• Studies that have recruited subjects with a primary diagnosis of schizophrenia. 
• Participants aged 18-64. 
 
The exclusion criteria were as follows: 
• Full text not published in English. 
• Papers published before January 2000. 
• Case studies, reviews, conference abstracts or book chapters. 
• Unpublished dissertations. 
• Studies that did not report on data for people with a diagnosis of schizophrenia 
spectrum disorder separate from other psychotic disorders. 
 
Search Results 
 
The electronic database search produced 460 studies, once duplicate papers were removed.  
These were examined according to the inclusion and exclusion criteria until 11 were 
deemed suitable for inclusion in the systematic review.  Hand searches of the reference lists, 
other reviews of relevance, and the two journals, did not produce any further studies.  
Figure 1 shows a flow-chart representing the search process described. 
 
 
       
INSERT FIGURE 1 HERE 
       
 
 
Assessment of Methodological Quality 
 
A scoring system was adapted specifically for this review to assess the methodological 
quality of the selected studies (Appendix 1.2).  It was modified from a scoring system 
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developed for another systematic review which looked at cohort studies (White, 2007).  The 
scoring system was based on the Scottish Intercollegiate Guidelines Network (SIGN, 2008) 
guidelines for assessing the quality of cohort studies, and also the Clinical Trial Assessment 
Measure (CTAM; Tarrier & Wykes, 2004).  The scoring system comprised four sections which 
assessed different areas of importance to consider when ascertaining methodological 
quality.  Each section was scored out of 25, which could be summed to produce a total score 
out of 100 for determining overall quality of the study.  An independent rater also scored a 
sample of 6 papers for methodological quality using the same framework.  Agreement rate 
was 89.2%, although this reached 100% once disagreements were discussed.    
 
 
Results 
 
Description of Studies 
 
Eleven studies were included in this review that reported on the association between 
positive symptoms and violence for individuals with a diagnosis of schizophrenia (see Table 
1 for a summary of these studies).  A total of 2623 participants were recruited across the 
studies (Median = 125; IQR: 156), of which 2131 (81.2%) were male and 492 (18.8%) were 
female.  The mean age of participants was 35.2 years (SD = 5.0).  Only three studies 
reported the ethnicity of the sample recruited (Joyal, Putkonen, Paavola, & Tiihonen, 2004; 
Swanson et al., 2006; Teixeira & Dalgalarrondo, 2009).  These samples together comprised 
participants from White (62.3%); African American (32.1%); other/not otherwise specified 
(5.6%) backgrounds.     
 
 
        
INSERT TABLE 1 HERE 
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Five studies recruited their samples from inpatient populations, whereas four recruited from 
community outpatient populations.  Two studies (Foley et al., 2007; Fresán et al., 2005) 
included a mixture of inpatient and outpatient participants in their sample (89% and 21% 
inpatients respectively).  The majority of the single-country studies were based in America 
(2 United States of America; 1 Canada; 1 Brazil; 1 Mexico), while the others were based in 
Western Europe (2 Finland; 1 Austria; 1 Ireland).  Two studies recruited their sample from 
more than one country (both recruited from Canada, Germany, Finland and Sweden).  
 
There was large variation in prevalence rates of violence identified between studies (Table 
2).  Prospective studies reported violence amongst 7.0% - 56.1% of participants, with follow-
up periods ranging from 14 weeks – 24 months.  In the retrospective studies, violence 
prevalence rates ranged from 19.1% - 63.9% and where stated, retrospective data were 
collected from a period beginning 2 weeks – 12 months previously.  Retrospective case 
control studies were excluded from this specific analysis since acts of violence were an 
inclusion criterion for entry to the study (Joyal et al., 2004; Stompe, Ortwein-Swoboda, & 
Schanda, 2004; Teixeira & Dalgalarrondo, 2009).   
 
 
         
INSERT TABLE 2 HERE 
         
 
 
Evidence for an Association between Positive Symptoms in Schizophrenia and Violence      
 
The findings of the eleven studies were conflicting.  Eight of the 11 studies reported a 
positive relationship between positive symptoms and violence (Chan, 2008; Foley et al., 
2007; Fresán et al., 2005; Hodgins et al., 2003; Joyal et al., 2004; Lincoln & Hodgins, 2008; 
Nolan et al., 2005; Swanson et al., 2006), implying the presence of positive symptoms 
increased the risk for violence in this population, compared to three studies that did not find 
evidence to support this hypothesis (of which one study looked at the relationship between 
positive symptoms and ‘excessive violence’ in convicted murderers with schizophrenia).  Of 
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note, there were wide variations in methodology employed amongst the studies, for 
example, in their design; the population samples were recruited from; definition and 
measurement of ‘violence’; measurement of positive symptoms; and statistical methods 
employed to assess the relationship between the variables of interest (Table 1 and Table 2).  
 
Retrospective studies 
 
Eight studies utilised a retrospective design.  Swanson et al. (2006) found that both minor 
and severe violence risk was significantly increased by the presence of positive symptoms 
(measured by above median positive PANSS (Kay, Fiszbein, & Opler, 1987) scores recorded 
up to six months after a violent incident occurred).  Adjusted odds ratios (ORs) for their final 
logistic regression model were 1.66 and 2.71 respectively.  However, negative symptoms 
were predictive of severe violence when entered into their model (specifically scores above 
median for the PANSS negative scale reduced the risk of severe violence, thus moderating 
the effect of positive symptoms).  This would be an expected outcome given that the 
presence of negative symptoms implies the participant would likely be withdrawn and have 
low mood, therefore reducing the opportunity and motivation for violence.  In addition, 
their findings also highlighted that risk of violence was significantly increased by other non-
clinical variables that were entered into their logistic regression model, including younger 
age and having a recent history of contact with police.   
 
Foley et al. (2007) investigated the relationship between duration of untreated psychosis 
with violence in first episode schizophrenia.  Using violence as an outcome (measured from 
participant file information over a two-week period), 12 potential predictor variables were 
entered into a binary logistic regression model (including duration of untreated psychosis; 
drug and alcohol misuse; insight).  Only positive symptom scores and involuntary admission 
status (both recorded within one week of a violent incident occurring) were significantly 
related to violence (no ORs were reported).  The findings are limited by the selective 
predictor variables entered into the model.  Furthermore, there are problems with causality 
in the study in that the relationship between involuntary admission status and violence is 
complex.  For example, given that severity of positive symptoms is a probable determinant 
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for an involuntary hospital ‘section’, it is likely that these variables are inter-related and the 
impact of this relationship cannot be fully examined within a logistic regression. 
 
Another study investigated the relationship between clinical symptoms and violence in 
outpatients and inpatients with schizophrenia (Fresán et al., 2005).  Having split their 
participants into a ‘violent’ or ‘non-violent’ group based on an assigned cut-off point on a 
measure of violence, they reported significantly higher severity ratings for the ‘violent’ 
group on some indices of positive symptoms, including ‘delusions’ and ‘hallucinatory 
behaviour’.  They reported that their findings suggested the severity of these symptoms play 
an important role in violence amongst this population. They also found a significant positive 
correlation between positive symptom and global violence ratings.   
 
Conversely, Teixeira and Dalgalarrondo (2009) reported there were no significant 
differences in positive symptom ratings between their ‘violent’ group (men who had 
committed a violent crime related to delusional symptoms) and their ‘non-violent’ control 
group (men with delusional symptoms who had no history of violent behaviour).  Perhaps 
this would be expected given both groups were selected on the basis of the presence of 
experiencing a particular positive symptom.  Further investigation into the dimensions of 
the delusions reported using the MacArthur-Maudsley Delusion Assessment Schedule 
(MMDAS; Appelbaum, Robbins, & Roth, 1999), by a researcher not blind to group allocation, 
revealed that scores for ‘refraining from acting because of the belief’ and ‘negative affect’ 
were significantly higher in the ‘non-violent’ group and scores for ‘acting on the belief’ were 
significantly higher in the ‘violent’ group.  Univariate logistic regression analysis revealed 
that these factors were significant when assessing the presence or absence of violence (OR 
= 0.64; 0.50; 4.09 respectively), relative to the other three dimensions of delusions 
measured.  The authors suggested that for delusional patients with schizophrenia who 
inhibit their behaviour based on a delusional belief, it is protective against violent behaviour 
if this is consistent with the actual delusions (e.g., the delusion causes them to avoid 
people/situations which might otherwise lead to violence).   
 
Two studies investigated the relationship between violence and positive symptoms by 
retrospectively examining the role of delusions and hallucinations in the crimes of homicide 
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offenders with schizophrenia.  Joyal et al. (2004) gathered information from multiple 
sources to ascertain whether or not the homicide(s) committed by participants with 
schizophrenia or a schizophrenia and anti-social personality disorder (APD) dual-diagnosis, 
were influenced by hallucinations or delusions (inter-rater alpha coefficient of intraclass 
correlation = 0.90).  They reported that these symptoms were the trigger to the homicidal 
act for 83% of participants in their schizophrenia group.  This was significantly different from 
the 46% of homicides committed as a consequence of experiencing hallucinations or 
delusions in their schizophrenia and APD group.  The latter group had a significantly higher 
proportion of homicidal acts triggered by having a fight/argument relative to the 
schizophrenia group. The authors argued this study highlights the influence co-morbidity 
may have on the role positive psychotic symptoms may play in violence.  However, the 
conclusions appear tautological, as receiving an APD diagnosis would require the presence 
of a history of violent behaviour characterised by fighting or assaults, beginning in late 
adolescence/early adulthood.      
 
Laajasalo and Häkkänen (2006) investigated whether hallucinations and delusions were 
related to use of ‘excessive violence’ during homicidal acts perpetrated by people with a 
diagnosis of schizophrenia.  Similar to Joyal and colleagues (2004), the actions that led to 
homicide for two thirds of their participants were deemed to be motivated by delusions 
and/or hallucinations, although again these symptoms could be recognised as being present 
but not thought to have motivated the crime (Cohen’s kappa values were not explicitly 
stated but reportedly indicated ‘significant inter-rater reliability’).  The study also reported 
evidence to suggest that delusions and hallucinations are not related to the use of excessive 
violence in homicides committed by participants.  Their logistic regression analysis model to 
predict use of ‘excessive violence’ found presence of hallucinations and delusions (OR = 
1.93; p = 0.13) and psychotic motivation for the homicide (OR = 0.53; p = 0.17) were not 
significant predictor variables.            
 
Stompe et al. (2004) investigated the link between violence and TCO symptoms in males 
with schizophrenia.  They compared a ‘violent’ group (comprising those who had committed 
a violent offence which had led to detainment in a high security institution) with a ‘non-
violent’ matched control group from psychiatric clinics.  Using stepwise forward logistic 
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regression, they reported that the addition of ‘TCO symptoms’ failed to improve the 
statistical significance of the model chi-square after ‘social origin’ and ‘substance-related 
disorders’ had first been entered into the model.  The authors argued their results did not 
support the basis for there being a relationship between TCO symptoms and violence 
generally.  However, their findings did suggest that TCO symptoms were associated with the 
severity of a violent offence.  The researchers attributed this specifically to the perceived 
‘threat’ component of the symptoms because there appeared to be no association between 
severity and the ‘control/override’ aspect of symptoms.   
   
Chan (2008) found that carer-rated intensity of TCO symptoms was the only significant 
factor that contributed towards physical assault of a relative with schizophrenia towards a 
caregiver when entered into their stepwise regression model.  Furthermore, this factor and 
‘critical comments’ were the only two found to significantly contribute towards the 
incidence of physical aggression against caregivers when entered into their model. 
 
Prospective studies      
 
A smaller number of studies utilised a prospective design.  Unlike the retrospective studies 
whereby researchers used violent acts already committed as an outcome, these studies 
instead looked at the presence/absence of violence during a specified future period.  In 
their study which aimed at investigating whether lack of insight was predictive of future 
violent behaviour, Lincoln and Hodgins (2008) followed up 216 ‘at risk of violence’ 
participants newly discharged from forensic and psychiatric hospitals over two years.  In 
total 27 (15.9%) participants were violent.  After entering measures of psychopathy, 
followed by positive symptoms and then insight into their stepwise logistic regression 
model, only positive symptoms (and to a lesser extent psychopathy) were predictive of 
whether or not a participant behaved violently.  Furthermore, by the final six months of 
their two-year follow-up period, only positive symptom scores were predictive of violence.  
Again this study is limited by the small number of predictor variables entered into their 
model and ORs were not reported.    
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Another study (Nolan et al., 2005) looked at the relationship between positive symptoms 
and violence in 157 ‘treatment-resistant’ inpatients with schizophrenia followed up over 14 
weeks.  During this period 88 (56.1%) participants were recorded as having had one or more 
violent incident.  After classifying participants as ‘aggressive’ (minimum of one violent 
incident during the study) vs. ‘non-aggressive’ (no incidents recorded), the researchers 
reported that severity of positive symptoms at baseline was significantly higher in the 
‘aggressive’ group, and there was some evidence to suggest that positive symptom measure 
scores became elevated in the days preceding the incident.  Effect sizes were not reported 
for these findings.   
 
The final prospective study (Hodgins et al., 2003) investigated symptoms that may precede 
violent behaviour in 128 male patients with schizophrenia discharged from psychiatric and 
forensic hospitals followed up over 12 months.  During the first six-month period nine out of 
128 (7.0%) participants behaved violently, followed by 11 out of 112 (10.2%) participants in 
the latter six-month period.  The authors reported from their logistic regression model that 
even after controlling for personality disorder, psychopathy and drug/alcohol misuse, the 
presence of any severe positive symptom increased the risk of violence during the first 6 
month period (OR = 5.15; 95% CI = 1.25 – 21.23), and during the second 6 month period (OR 
= 11.19; 95% CI = 2.72 – 46.00).  Furthermore, in the latter 6 month period having at least 
one TCO symptom (OR = 7.69; 95% CI = 1.90 – 31.19), and an increase in these symptoms 
between the two periods (OR = 10.03; 95% CI = 2.61 – 38.52), was also predictive of violence 
in their community sample after controlling for the same three variables.  Of note, the large 
confidence intervals for these entire findings highlight the uncertainty of the ORs reported, 
which can be attributed to the small number of participants who were violent during the 
two 6-month periods that were studied.  Therefore, these ORs need to be interpreted with 
caution.          
 
Methodological Quality of Studies 
 
The eleven studies selected for review were scored and ranked for methodological quality 
(see Table 1) using the tool developed for this purpose (Appendix 1.2).  Some notable issues 
regarding methodological quality are worthy of further discussion. 
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Of the 11 studies included for review, only three employed a prospective design.  This 
design is more desirable for cohort studies.  Furthermore, given that violent behaviour is 
often variable in terms of both frequency and severity, and the variables that may predict 
this behaviour (including positive symptoms) are also dynamic, a prospective design would 
allow for greater opportunity to observe change over time.   
 
Indeed, the proximity of assessment of positive symptoms to violent behaviour was variable 
across the retrospective (and prospective) studies.  For some studies there was an 
indeterminate amount of time between assessment of positive symptoms and recorded 
violent behaviour(s) (Foley et al., 2007; Stompe et al., 2004; Teixeira & Dalgalarrondo, 2009) 
or a potential gap of 6-12 months between the time the two variables under investigation 
were measured (Chan, 2008; Hodgins et al., 2003; Lincoln & Hodgins, 2008; Swanson et al., 
2006).  Two studies assessed positive symptoms in close proximity to their measures of 
violence.  Fresán et al. (2005) measured violent behaviour in the week preceding the clinical 
assessment when they measured positive symptoms.  Nolan et al. (2005) performed 
secondary analyses of data for when they had positive symptom measure scores that were 
recorded within three days of violent behaviour taking place.   
 
Not only does the proximity of the positive symptom and violence assessments vary across 
the studies reviewed, but also how these factors are assessed and defined.  The definition of 
violence as an outcome was varied, ranging from verbal aggression, which was considered 
as one part of a broader definition (e.g., Hodgins et al., 2003) to homicide only (Joyal et al., 
2004; Laajasalo & Häkkänen, 2006).  As one would expect from such diversity in definition, a 
wide range of violence outcome measures were used.  These included validated measures 
such as the Overt Aggression Scale (OAS; Yudofsky, Silver, Jackson, Endicott, & Williams, 
1986) to recording whether or not the participant had committed a homicidal offence or a 
‘violent crime’.  Further to the variation in measurement of violence, positive symptom 
measurement was also disparate.  Although positive symptoms were most commonly 
assessed by the PANSS, some studies used the total score for the PANSS Positive Symptoms 
subscale, whereas others looked at the individual factors that make up this subscale (e.g., 
Swanson et al., 2006).  More varied still, some studies looked for the presence of 
‘hallucinations’ or ‘delusions’ recorded in case notes (Joyal et al., 2004; Laajasalo & 
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Häkkänen, 2006).  Studies looking at TCO symptoms were equally varied.  Two studies used 
information from interview schedules to draw conclusions about symptoms: Hodgins et al. 
(2003) used the Psychiatric Epidemiology Instrument (Link & Stueve, 1994) whereas Stompe 
et al. (2004) used the SADS: Lifetime Version (SADS-L; Spitzer & Endicott, 1977) and 
Fragebogen zur Erfassung Psychotischer Symptome (FPS; Stompe & Ortwein-Swoboda, 
1999).  Chan (2008) used a self-report measure completed by carers (i.e., TCO symptoms 
scale; Bjørkly & Havik (2003)).  Such variation in definition and measurement of constructs is 
likely to have implications for the consistency and generalisability of findings, which may 
explain the differences in the literature.  This is further confounded by the apparent 
population selection biases evident in the above studies.  
 
Perhaps also related to this point, the difference in statistical analysis methods used across 
studies could also contribute towards the disparity of findings.  For example, some studies 
used statistical tests of difference to look for differences between a ‘violent’ and ‘non-
violent’ group of participants, of which group membership was defined by criteria specific to 
the study.  Therefore, these tests could end up essentially measuring different things, as 
group allocation was inconsistent across studies.  Thus to say there was a difference in 
positive symptoms between the groups in one study does not permit one to conclude that 
there should be differences between others, despite utilising similar statistical analysis 
methods.  
 
It is also worth mentioning some of the difficulties inherent to using logistic regression 
analysis to report whether or not there is evidence to suggest an association between 
violence and positive symptoms in schizophrenia, as many of the studies chose this 
approach to analysis.  The significant predictors of violence are only significant within the 
context of the specific model the researchers have developed, which is dependent upon the 
other variables entered into the model which are non-significant.  Whereas some studies 
appeared to have entered many other variables derived from those the literature would 
suggest may be associated with violence (e.g., Swanson et al., 2006), others seemed to have 
relatively small models for which there did not appear to be many competing variables 
entered into the model (e.g., Stompe et al., 2004).  This of course means that any significant 
results should be interpreted with caution, as other omitted variables may have explained a 
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significant proportion of the variance in violent behaviour.  Importantly, several studies did 
not report on history of violence, which could have shown to be an important variable, were 
it entered into a logistical regression model.   
 
Perhaps another limitation of the use of logistic regression analysis relevant to its use in 
prospective studies is the issue that this design sets a limited follow-up period.  Therefore, 
the set time period actually becomes a confounding variable in the analysis.  For this reason, 
Cox regression may be more appropriate as it allows for missing (or censored) data, i.e., 
events that have not occurred within the observation period but may yet occur.  In this way 
the variable ‘time to event’ can be fully incorporated into analyses.   
 
The above studies all suffered from inconsistent and insufficient reporting of their results.  
For example, the studies using logistical regression analysis often failed to report ORs (and 
confidence intervals), and none reported relative risk ratios.  Furthermore, when significant 
findings were reported, their clinical significance was often over-inflated, given the actual 
small OR values.  On the theme of over-inflating findings, the majority of the studies above 
suffered from drawing tautological conclusions which could often be inferred from a logical 
consideration of what was being measured.  For example, it is common sense for one to 
infer that someone with an APD diagnosis who has committed a murder likely did so as the 
result of getting into a fight or argument (Joyal et al., 2004), and delusional participants who 
are violent are more likely to have acted on their delusional belief than delusional 
participants who were not violent (Teixeira & Dalgalarrondo, 2009). 
 
 
Discussion 
 
Main Findings 
 
This review aimed at exploring the evidence for an association between the presence of 
positive symptoms and violence in people with schizophrenia from the past decade, and at 
considering what this can tell us about the relationship or underlying mechanisms between 
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these two variables.  Therefore, this review sought to update the findings of previous 
reviews (e.g., Bjørkly, 2002a; 2002b; Braham, et al., 2004; Walsh et al., 2002). 
 
Of the 11 studies reviewed, where possible to calculate, prevalence rates of violence 
amongst participants with schizophrenia ranged from 7%-63.9%, assessed over a timeframe 
spanning 2 weeks – 2 years.  In total, eight (73%) of the studies concluded that there was a 
positive association between the presence of positive symptoms and violence in people with 
schizophrenia.  Since seven of the studies reported on positive symptoms generally, it is 
difficult to be more specific about the nuances of positive symptoms that might underpin 
this relationship, or draw comparisons with reviews that have focused on a specific positive 
symptom, such as delusions (e.g., Bjørkly, 2002a) or hallucinations (Bjørkly, 2002b; Braham, 
et al., 2004).  This is further complicated by the definitions of the dependent variable, 
‘violence’, ranging from ‘verbal aggression’ to ‘homicide’.  However, taken together, the 
pattern of findings reported here echo those of other reviews, with the evidence suggesting 
that there is an association between these factors.  For example, Bjørkly (2002a) concluded 
that the literature advocated for the role of persecutory delusions in increased risk for 
violence amongst psychiatric patients.  Also to a lesser extent there was some emerging 
evidence that suggested command hallucinations (which were violent in content) may be 
associated with a greater risk of violence by way of the fact that they may increase 
compliance, which would cause a violent outcome.  Of the two studies reviewed here which 
made specific reference to delusions and hallucinations, one (Joyal, et al, 2004) reported a 
significant association for the role of these symptoms in homicide, whereas another 
(Laajasalo & Häkkänen, 2006) reported these variables were not related to the use of 
‘excessive violence’ amongst homicide offenders with schizophrenia, although clearly these 
two studies were measuring different things.   
 
Three of the studies looked at the relationship between TCO symptoms and violence with 
two advocating for a positive association (Chan, 2008; Hodgins, et al., 2003) and one not 
(Stompe, et al., 2004).  This disparity of findings was also reflected in a previous review 
which looked at eight studies and reported that seven found that acute psychotic symptoms 
(such as TCO symptoms) were associated with increased risk of violence amongst people 
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with a psychotic illness (including schizophrenia), and one study that did not find evidence 
for this association (Walsh et al., 2002).   
 
There are limitations in interpreting the findings of the studies reviewed due to the broad 
variation in design; methodology; participants; definition and measurement of variables; 
statistical analysis; and overall methodological quality, thus only tentative conclusions can 
be drawn about what these studies can collectively tell us about the role positive symptoms 
may play in the increased risk of violence amongst this diagnostic group and the underlying 
mechanisms.  For example, various definitions of the two variables measured were 
employed across the studies.  While the definition of ‘violence’ ranged from verbal 
aggression to homicide, the definition of what constituted ‘positive symptoms’ was equally 
disparate.  Specifically this ranged from a dichotomous classification system (positive 
symptoms absent/present) to classifying participants in terms of a specified amount or 
intensity of positive symptoms experienced (for example, through the use of a pre-
determined cut-off score on the PANSS positive symptom scale).  This of course has 
implications for making comparisons across the studies reported in this review.  In addition, 
there was variation in the proximity of symptom measurement to violent events.  Thus, it is 
possible other confounding factors could have contributed towards the violence, which is 
further exacerbated by the statistical models used being restrictive in the competing 
variables accounted for.  Furthermore, given the dynamic nature of violence and positive 
symptoms in schizophrenia, a prospective design would have been more desirable in order 
to achieve greater control, although only three studies utilised this.  Thus, all things 
considered, it appears that little has improved over the past decade in this field of research, 
as similar observations were made in previous reviews.  For example, Walsh et al. (2002) 
commented on the discrepancy in methodologies employed by the studies reviewed, which 
made it difficult to draw conclusions with any confidence.  Furthermore, they recommended 
that methodologies could be improved by better controlling for bias in the studies and using 
more than one measure of violence in a single study, which appears to have not been 
addressed over the past decade.  Similarly, Bjørkly (2002a; 2002b) concluded that 
comparison of the findings across studies and generalisability was severely limited by the 
heterogeneity and inadequacies of methodologies. 
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Limitations of Review 
 
This review has focused on a single diagnostic group, which may be of less relevance to 
clinicians who are more concerned with the symptoms a psychiatric patient presents with 
than the diagnostic label per se.  However, as highlighted by Hodgins et al. (2003) drawing 
comparisons across diagnostic groups could confound the findings as the association 
between the violence and positive psychotic symptoms may differ depending on diagnosis.  
Furthermore, given that often the most common diagnosis given in secure hospital settings 
is schizophrenia (e.g., Taylor et al., 1998), and clinicians within these settings often work 
within a diagnostic framework, ecological validity is assumed. 
 
A further limitation is that the review only considered research from the past 11 years.  
However, the findings presented here can be seen as updating those presented in earlier 
reviews (Bjørkly, 2002a; 2002b; Walsh et al., 2002) which include research published prior to 
2000.  Furthermore, this systematic review does not include a meta-analysis which could 
improve the applicability of the findings presented.  However, the degree of diversity in the 
definitions of violence and positive symptoms, sampling procedures, measures used and 
statistical analyses would pose significant difficulties for combining the data, when also 
given that the quality of the data is already problematic. 
 
Conclusions 
 
Considering the overall findings of this review, there is some evidence to suggest that the 
presence of positive psychotic symptoms in people with a diagnosis of schizophrenia may 
increase the risk for violence in this population.  However, the variation of the research 
methodologies does not allow for further speculation on the type of positive symptom or 
the underlying mechanisms that might explain the relationship.  As a caveat, extreme 
caution must be taken when interpreting these findings as they are constrained by 
limitations to methodological and statistical rigour, as discussed in this review.  Often there 
is the potential for confounding factors to explain a portion of the variance for increased risk 
of violence in the studies, which is often not addressed.  Furthermore, when significant ORs 
are reported, the clinical significance of the ‘increased risk’ for violence remains minor, 
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particularly given the low base rates of violence to begin with.  Thus, it is important to 
remember when interpreting the findings of these studies that violence amongst people 
with schizophrenia is extremely rare and therefore although there may be some evidence 
for there being a positive relationship between positive symptoms and violence amongst 
this population, given the low base rates of violence, positive symptoms are neither 
necessary nor sufficient for violent behaviour to occur.  This is reflected by the large 
proportion of people with schizophrenia who experience positive symptoms, but the 
comparatively low base rate of violence amongst this population.  Furthermore, some 
studies (e.g., Laajasalo & Häkkänen) reported that violence occurred amongst their sample 
of participants with schizophrenia in the absence of experiencing positive symptoms.    
 
It is important not to add further to the stigmatisation of this population, and therefore 
further research is warranted which addresses some of the concerns described here, before 
conclusions can be made with confidence about the association between positive psychotic 
symptoms and violence in schizophrenia, and the possible underlying mechanisms which 
may control this relationship.  Only once more is known about this association will 
appropriate and effective risk management strategies be able to be implemented.     
 
Implications for Future Research, Clinical Practice and Service Planning   
 
Future research that looks at the relationship between violence and positive psychotic 
symptoms in schizophrenia should aim at taking a more consistent approach.  Researchers 
should aim for greater consistency in design; population sampling; definition of violence as 
an outcome; measurement of violence and positive psychotic symptoms; and greater 
transparency in statistical analysis, including more careful consideration of confounding 
variables and clearer reporting of ORs and effect sizes.  Furthermore, as none of the 
research in this field over the past eleven years was based in the United Kingdom, this 
should be addressed to ensure greater generalisability of findings.     
 
However, given that there is some (cautionary) evidence to suggest there is an association 
between the presence of positive psychotic symptoms and violence in people with 
schizophrenia, this should be born in mind when assessing and formulating risk of violence 
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in this client group.  Of course base rates of violence are very low, and are far outweighed 
by the number of people who show signs of positive symptoms, but this issue may be 
particularly relevant to services who work with people with a history of violence, such as in 
forensic mental health settings.  Changes to service and risk management planning should 
be made accordingly.   
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Figure 1. Flow chart depicting search process.   
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(n = 35) 
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Table 1. Summary of methodology for the 11 studies 
Study Quality criteria 
rating (Rank) 
Design Participants recruited Measure of Violence Measure of Positive 
Symptoms 
Chan (2008) 53.5% (=2) Retrospective 61 caregivers who provided care for 51 relatives with schizophrenia; 
(Canada). 
Revised Conflict Tactics Scales 
(CTS2); (Straus, Hamby, Boney-
McCoy, & Sugarman, 1996).  
TCO symptoms scale. 
Foley et al (2007) 48.5% (6) Retrospective 94 individuals with schizophrenia (first-episode); (59 M, 35 F); (85 
inpatient, 9 outpatient); (Ireland). 
Modified Overt Aggression 
Scale (MOAS); (Kay, 
Wolkenfeld, & Murrill, 1988). 
PANSS. 
Fresán et al (2005) 41% (9) Retrospective 
 
100 individuals with schizophrenia; (65 M, 35 F); (21 inpatient; 79 
outpatient); (Mexico). 
OAS. PANSS. 
Hodgins et al (2003) 61% (1) Prospective 
 
128 M with schizophrenia (n = 106) or schizoaffective disorder (n = 22) 
discharged from forensic psychiatric hospital (n = 37) or general 
psychiatric hospital (n = 91); (Canada; Germany; Finland; Sweden).   
Interview protocols developed 
by the MacArthur Risk 
Assessment Project. 
General ‘positive 
symptoms’: PANSS; TCO 
symptoms: questions 
from the Psychiatric 
Epidemiology Instrument.  
Joyal et al (2004) 32.5% (=10) Retrospective Last 58 M with schizophrenia convicted of murder, attempted murder, 
manslaughter or attempted manslaughter and committed to treatment 
before January 1998; (Finland). 
Homicidal offence committed.  Independent ratings of 
presence of ‘delusions’ 
and/or ‘hallucinations’ at 
time of offence from file 
information. 
Laajasalo & Häkkänen 
(2006) 
32.5% (=10) Retrospective 125 M homicide offenders (1986-2004) with schizophrenia; (Finland). Homicidal offence committed 
(and further classified as 
‘excessive violence’ used or 
not). 
Independent ratings of 
presence of ‘delusions’ 
and/or ‘hallucinations’ at 
time of offence from file 
information. 
Lincoln & Hodgins 
(2008) 
52.5% (4) Prospective 216 individuals with schizophrenia; (209 M, 7 F); discharged from 
forensic hospitals (n = 127) or general psychiatric hospitals (n = 82); 
(Canada; Germany; Finland; Sweden). 
MacArthur Community 
Violence Instrument 
(Steadman et al., 1998).  
PANSS. 
Nolan et al (2005) 51% (5) Prospective 157 ‘treatment-resistant’ inpatients with schizophrenia; (133 M, 24 F); 
(USA). 
OAS. PANSS. 
Stompe et al (2004) 43.5% (8) Retrospective 
 
119 M inpatient ‘violent offenders’ with schizophrenia vs. 105 M 
inpatient age-matched ‘non-offenders’ with schizophrenia; (Austria). 
Taylor (1985) classification of 
violent behaviour. 
SADS-L; FPS. 
Swanson et al (2006) 53.5% (=2) Retrospective 1410 individuals with schizophrenia; (1048 M, 362 F); mixed 
inpatient/outpatient (some both); (USA).  
MacArthur Community 
Violence Interview (Steadman 
et al, 1998). 
PANSS. 
Teixeira & 
Dalgalarrondo (2009) 
46% (7) Retrospective 
 
30 M delusional inpatients (high-security forensic hospital) with 
schizophrenia who had committed a violent crime related to their 
delusional behaviour vs. 30 M delusional inpatients (common 
psychiatric wards) with no history of violent crime; (Brazil). 
Committed a ‘violent crime’. PANSS; MMDAS.  
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Table 2. Summary of results of the 11 studies. 
Study Prevalence rate of 
violence reported 
(time period) 
Statistical Analysis Conclusions drawn re: relationship between positive symptoms in 
schizophrenia and violence 
Chan (2008) 63.9% (in the last 12 
months). 
• Inter-correlations between dependent (inc. 
TCO symptoms) and independent (physical 
assault/psychological aggression) variables 
• Stepwise regression analyses for variables 
explaining ‘physical assault’ and then 
‘psychological aggression’ against caregivers 
Positive relationship 
• Primary risk factors for ‘psychological aggression’ against caregivers are 
level of critical comments given and severity of TCO symptoms. 
• Primary risk factor for ‘physical assault’ against caregivers is severity of 
TCO symptoms. 
Foley et al (2007) N = 30 (32%) of 
participants (over 2 week 
period). 
• Binary logistic regression to identify possible 
predictors of violence (10 factors entered into 
model inc. PANSS positive symptom subscale 
score). 
Positive relationship 
• ‘Involuntary admission status’ and ‘higher PANSS positive symptom 
scores’ were the only 2 significant predictor variables entered into the 
model.    
Fresán et al (2005) N = 20 (20%) (observation 
period unknown). 
• Statistical tests of difference (Chi square for 
categorical differences and Mann Whitney U 
for independent samples differences) between 
‘violent’ (n = 20) and ‘non-violent’ (n = 80) 
participants on multiple variables (inc. all 
subscales of PANSS positive subscales scores). 
• Correlations of PANSS scores and ‘Global 
Aggressiveness’ scores on OAS.  
Positive relationship 
• Significant differences between groups on 4 out of 7 PANSS positive 
subscale dimensions (‘violent’ group significantly higher). 
• Significant positive correlation between ‘global aggression’ and PANSS 
positive subscale scores (and for 5 out of 7 positive subscale 
dimensions).  
Hodgins et al (2003) N = 9 (7.0%) of 
participants (0-6 months); 
N = 11 (10.2%) of 
participants (6-12 
months). 
• Tests of difference for ‘violent’ vs. ‘not violent’ 
for the two 6 month periods (inc. PANSS 
positive symptom scores and TCO symptom 
scores). 
• Logistic regression models to predict violence 
at both 6 month periods.  Measures of 
positive, negative, and TCO symptoms, anxiety, 
and depression entered into the models. 
Positive relationship 
• During first 6 month period presence of severe positive symptom at 
beginning predicted violence (even after controlling for APD diagnosis, 
psychopathy and history of drug/alcohol misuse). 
• During second 6 month period, presence of severe positive symptom, a 
TCO symptom, and an increase in TCO symptoms at the start of the 
period, predicted violence (even after controlling for APD diagnosis, 
psychopathy and history of drug/alcohol misuse). 
Joyal et al (2004) 100% (entrance to study 
was defined by having 
committed a homicide 
offence). 
• Tests of difference across several variables (inc. 
types of delusions and hallucinations deemed 
to have triggered the homicidal act) between 
participants with a schizophrenia diagnosis and 
participants with a schizophrenia-APD dual 
diagnosis. 
Positive relationship 
• Psychotic symptom(s) judged as trigger in N = 35 (60%) of all the 
homicides. 
• Significant difference for psychotic symptom(s) as trigger between 
schizophrenia (n = 19 (83%)) and schizophrenia+APD (n = 16 (46%)) 
groups.   
• APD dual diagnosis may reduce impact of psychotic symptoms triggering 
this type of violence (significantly more homicides in schizophrenia+APD 
group were judged to be triggered by a fight or argument).  
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Table 2. continued. 
Laajasalo & Häkkänen 
(2006) 
100% (entrance to study 
was defined by having 
committed a homicide 
offence). 
N = 37 (29.6%) judged to 
have used ‘excessive 
violence’ (the independent 
variable in this study). 
• Tests of difference between non-excessive 
violence vs. excessive violence groups. 
• Logistic regression analysis for predicting use 
of excessive violence (variables entered 
included ‘hallucinations and delusions’ and 
‘psychotic motivation’).   
• A separate logistic regression analysis was 
conducted to predict excessive violence based 
on psychotic symptoms present in a sub-
sample of psychotically motivated offenders (n 
= 85).  
No significant relationship 
• Hallucinations and delusions, and psychotic motivation were not 
significant predictor variables for excessive violence in their model. 
• In a ‘psychotically motivated’ sub-sample, no single psychotic symptom 
entered into the model was found to be predictive of excessive 
violence.  
Lincoln & Hodgins (2008) N = 27 (15.9%) of 
participants (over 2 year 
follow-up period). 
• Forward stepwise logistic regression analyses 
over four 6-month follow-up periods with 
violence as outcome (psychopathy measure, 
then PANSS positive factor, then PANSS insight 
rating were the dependent variables entered 
into the model). 
Positive relationship 
• Although none of the variables were predictive of violence during the 
first 6 month period, psychopathy and severity of positive symptoms 
predicted violence during the second and third 6 month periods.  By the 
fourth 6 month period, only severity of positive symptoms was 
predictive of violence. 
Nolan et al (2005) N = 88 (56.1%) of 
participants (over 14 week 
period). 
• Between group differences were investigated 
for ‘violent’ vs. ‘not violent’ participants during 
the study period on PANSS scores. 
• Temporal relationship between positive 
symptoms and violence was investigated by 
analysing group differences for PANSS data 
within three days of a violent incident 
occurring. 
Positive relationship 
• Significant differences were reported between groups on PANSS 
positive subscale scores, suggesting severity of positive symptoms is 
associated with violence. 
• Positive symptom severity was found to be increased in the days 
immediately prior to a violent incident occurring. 
Stompe et al (2004) N = 119 (100%) of study 
group participants 
(compared with non-
violent control group; N = 
105). 
• Tests of difference used to make between 
group comparisons (‘violent offenders’ vs. 
‘non-offenders’; ‘high violence’ vs. ‘low 
violence’ offenders) on a variety of variables 
(inc. TCO symptoms).   
• Stepwise forward logistic regression models for 
risk of violence, and risk of ‘high violence’ 
completed (variables entered: social origin, 
then substance-related disorders, then TCO 
symptoms). 
No significant relationship 
• No significant difference between ‘offender’ and ‘non-offender’ groups 
on prevalence of TCO symptoms. 
• TCO symptoms were not predictive of violence in stepwise forward 
logistic regression model after ‘social origin’ and ‘substance-related 
disorders’ entered. 
• However, ‘high violence’ group reported significantly higher prevalence 
of TCO symptoms than ‘low violence’ group, which was a significant 
predictor of high violence in the stepwise forward logistic regression 
model.  Attributed this to ‘threat’ symptoms.  
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Table 2. continued. 
Swanson et al (2006) N = 270 (19.1%) of 
participants (over 6 month 
period). 
• Mixed-model logistic regression was used to 
estimate multivariable models, with 3 
dichotomous outcome measures: (minor 
violence vs. no violence; serious violence vs. no 
violence; any violence vs. no violence).   
• Final models were presented with significant 
covariates from domain models entered.  
Positive relationship 
• Minor violence was found to be related to positive symptoms (higher 
PANSS positive scores), amongst 7 non-clinical characteristics and 4 
other clinical characteristics. 
• Serious violence was reported to be associated with positive symptoms 
(above-median PANSS positive scores), but above-median PANSS 
negative scores reduced risk.  Five other clinical/non-clinical 
characteristics were also related to risk.   
Teixeira & Dalgalarrondo 
(2009) 
N = 30 (100%) of 
participants in study 
group; N = 30 (0%) of 
participants in control 
group. 
• Tests of difference (Mann-Whitney) between 
study and control group were carried out for 
PANSS sub-scale scores and MMDAS dimension 
scores. 
• Univariate logistic regression analysis model 
for risk of violence, entering the 6 MMDAS 
dimensions as dependent variables. 
No significant relationship 
• No significant differences were found between groups on any of the 
PANSS subscales. 
• Significant differences were found on 3 of the MMDAS dimensions, and 
2 (‘acting on belief’; ‘refraining from acting because of belief’) were 
significant predictors of violence. 
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Lay Summary 
 
Our ability to think about our own thoughts and emotions, and those of others, and use this 
information to solve problems (metacognition) has been shown to be impaired in people 
diagnosed with the mental health condition, schizophrenia.  This impairment is thought to 
be related to many of the difficulties people with schizophrenia experience.  However, no 
research has looked before at whether it could be related to violence in people with this 
mental health condition, which although very rare can be problematic.  This study explored 
this by interviewing a group of people with schizophrenia who had a history of violence and 
a group who did not, and comparing them on their metacognition skills.  The results showed 
there was no difference between the groups on this ability, suggesting it is not related to 
violence in people with schizophrenia.  However, some aspects of their metacognitive skills 
were better than others, which may be relevant more generally to the difficulties 
experienced by people with this diagnosis.  Understanding this can help us to develop better 
psychological treatments for this group which take on board their pattern of difficulties with 
metacognition.    
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Abstract 
 
Metacognition has been shown to be impaired in people with schizophrenia, and related to 
poorer social functioning outcomes.  To date, no research has looked at the relationship 
between a particularly rare – but problematic – social functioning outcome (violence) and 
metacognition.  The present study aimed at doing this by exploring patterns of 
metacognition in people with schizophrenia and a history of interpersonal violence, and 
comparing them to a group with schizophrenia and no history of violence.  Participants took 
part in an interview which explored stress and coping, which was subsequently coded for 
metacognitive ability.  Results indicate that metacognitive functioning is not directly 
associated with violence as an outcome in schizophrenia, as metacognition did not differ 
significantly between the two groups.  However, results revealed that metacognition has a 
hierarchical structure with some domains more impaired than others, which may be 
relevant to the observed social functioning outcomes in schizophrenia.  The limitations of 
the study and implications for clinical practice and future research are discussed.  
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Introduction 
 
Metacognition 
 
‘Metacognition’ is the term used to describe an extraordinary set of higher-order skills 
inherent to human functioning.  Specifically, it describes the ability to think about thinking 
through our awareness and representation of one’s own and others’ cognitive and 
emotional states (mental states) and the use of this information to solve interpersonal 
problems (Semerari et al., 2003).  Although the use of a single term to describe this skill may 
suggest it represents a single entity, current thinking views metacognition as comprising 
several capabilities which are related to one another, but are nevertheless distinct, both 
from a neurobiological and social functioning perspective (Bosco et al., 2009).   
 
Within the literature, metacognition shares many conceptual similarities with other 
constructs, but the different theoretical orientations from which these have derived from is 
reflected in the differences between them.  For example, ‘theory of mind’ (ToM) is one such 
construct often used interchangeably with metacognition in the literature.  ToM reflects a 
strong cognitive focus to a social cognitive capacity, and refers to the ability to represent 
one’s own and others’ mental states, usually in relation to thoughts and beliefs (Brüne, 
2005).  Although ToM reflects a crucial part of metacognition, it is likely that it only 
represents one part of a wider system that allows one to think about thinking (Lysaker et al., 
2010a).  Combining ToM with psychoanalytic ideas, ‘mentalization’ describes another similar 
concept which has strong theoretical links to affect regulation, and is defined as the capacity 
to view mental states as independent from – but potentially able to influence – actions 
(Bateman & Fonagy, 2004).  Furthermore, mentalization has a strong developmental basis, 
and it is argued that the skill is formed by secure early attachment relationships.  In the 
absence of the opportunity to form a secure attachment early on, the capacity for 
mentalization can fail to develop sufficiently and impairments can emerge, for example in 
affect regulation abilities  (Choi-Kain & Gunderson, 2008).  Metacognition overlaps with the 
theoretical orientations of ToM and mentalization.  However, it emerged within a 
psychotherapeutic context, and thus represents a similar but distinct set of ideas, being 
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more concerned with the relationship between metacognitive abilities and 
psychopathology.     
 
Increasingly, the various roles and functions of metacognition are being recognised as 
important concepts in many different psychiatric disorders, for example personality 
disorders, eating disorders and post-traumatic stress disorder (PTSD) (Dimaggio, Vanheule, 
Lysaker, Carcione, & Nicolò, 2009).  In particular, the relationship between metacognition 
and schizophrenia has received much attention over recent years.   
 
Metacognition in schizophrenia 
 
Traditionally, research in this area has drawn on laboratory-based paradigms that look at 
ToM ability in people with schizophrenia using adaptations of psychological tests commonly 
used with children; measures of “intentionality”; or tests of first- and second-order ToM 
which assess comprehension of irony, faux pax, humour, and metaphor.  Although these 
studies suggest a specific deficit in ToM abilities in people with schizophrenia (Brüne, 2005), 
the limited generalisability of experimental laboratory tasks with people with psychiatric 
disorders to real-life situations warrants caution when interpreting the findings of these 
studies (Simpson, Done, & Vallée-Tourangean, 1998).   
 
In response to some of these difficulties, Lysaker and colleagues have explored 
metacognitive deficits in people with schizophrenia through the study of narratives of self 
and illness (Lysaker et al., 2005; Lysaker, Dimaggio, Buck, Carcione, & Nicolò, 2007b; Lysaker 
et al., 2008; Lysaker et al., 2010a; Lysaker et al., 2010b), which they argue allows for greater 
ecological validity in the study of metacognition through the construction of a real-world 
context, as reflected in narratives, as opposed to that offered by the analogous laboratory 
tasks (Lysaker et al., 2005). 
 
The findings from this body of research derived from narrative data have produced some 
interesting thoughts about metacognition in people with schizophrenia.  For example, the 
evidence suggests that the majority of people with this diagnosis show impairments in 
metacognitive functioning, such as their ability to recognise their own mental states, and/or 
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being able to perceive the world as a place where other individuals with their own unique 
thoughts, feeling and perspectives co-exist (Lysaker et al., 2007b).  Furthermore the 
evidence suggests that different clinical correlates may differentially affect metacognitive 
ability.  In one such example, features common in people with a diagnosis of schizophrenia, 
for instance: specific aspects of neurocognition, negative symptoms, and having a history of 
childhood sexual abuse have been shown to be independently linked to different patterns of 
metacognitive impairment (Lysaker et al., in press).  This further suggests metacognition has 
a modular quality, and is comprised of a set of semi-independent functions.  In addition, 
mood (e.g., depression), insight and quality of life have also been shown to be associated 
with impairments in metacognitive ability (Lysaker et al., 2005).   
 
Metacognition is further relevant for people with schizophrenia as it may act as a mediating 
factor to some of the negative outcomes and symptoms associated with this diagnostic 
group (Lysaker et al., 2010c).  In other words, some of the symptoms common in people 
with schizophrenia, such as positive and negative symptoms, and other associated 
diagnostic outcomes, may be reflective of underlying difficulties in different areas of 
metacognitive functioning (Lysaker, Gumley, & Dimaggio, 2011b).  For example, it is possible 
for one to conceive how having difficulties in being able to recognise and differentiate one’s 
own, and/or others’ mental states, and using this information to resolve problems, may 
have a negative impact on social functioning (Stratta, Daneluzzo, Riccardi, Bustini, & Rossi, 
2009).  Furthermore, it is also reported to have implications for occupational functioning, in 
so much as perhaps not being able to recognise and alter one’s thoughts about issues in the 
workplace may prevent an individual from being able to make the appropriate changes to 
performance in line with changes to workplace demands (Lysaker et al., 2010a).  Thus 
conceivably, metacognitive functioning in people with schizophrenia may have wide-
reaching implications for the recovery process in people within this diagnostic group.  
Consequently, metacognitive functioning has been viewed to be a potentially important 
target for psychosocial interventions with people with schizophrenia (Stratta et al., 2009). 
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Metacognition, schizophrenia and violence 
 
In response to these findings, researchers have begun to look further into the different 
patterns of metacognitive abilities and problems that exist in people with schizophrenia.  
Furthermore, they have considered how to develop interventions that may directly target 
these deficits in order to provide some resolution to many of the difficulties faced by people 
with schizophrenia.  Perhaps one population metacognition may be particularly relevant to, 
and interesting to consider, is amongst people with schizophrenia who have a history of 
interpersonal violence, who are often treated within the forensic mental health system.         
 
Although violence amongst people with schizophrenia is uncommon (Swanson et al., 2006), 
it is nevertheless problematic, particularly in forensic services where around half of those 
detained have committed violent or sexual offences (Rutherford & Duggan, 2008).  
Furthermore, poor outcomes that are more generally associated in people with 
schizophrenia can be particularly pronounced amongst this group; for example, social 
functioning.  The use of interpersonal violence to resolve conflict can be viewed as one 
extreme of a social functioning spectrum (Krakowski, 2003). 
 
Although the issue of violence amongst people with schizophrenia is undoubtedly complex, 
and both the underlying causes and functions multi-faceted, given the proposed link 
between metacognitive abilities and symptom expression and functioning outcomes, it is 
interesting to consider the relationship between metacognition and violence.  For example, 
one may propose at a theoretical level that any impairment in the ability to recognise and 
interpret internal cognitive and emotional states, and to recognise and interpret others’ 
mental states, and use this information to resolve interpersonal problems that one faces, 
may be particularly relevant to people with schizophrenia and a history of interpersonal 
violence.  Certainly Levinson and Fonagy (2004) have proposed that individuals with 
impairment in the capacity to envisage others’ mental states might be more likely to cause 
harm to others, as this mental state information is what ordinarily inhibits harmful 
behaviour because it allows us to perceive the views of others.  It further seems plausible to 
consider that metacognition may be related to the use of violence by a minority of this 
population, given that many of the identified violence recidivism risk factors are likely 
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vulnerable to impaired metacognitive ability, for example, lack of personal support, lack of 
insight, and impulsivity (Webster, Douglas, Eaves, & Hart, 1997).     
 
Exploration of metacognition in people with schizophrenia and a history of interpersonal 
violence could allow for further consideration of effective treatment and rehabilitation 
strategies for this population.  Although central to the rehabilitation and recovery goals for 
this group is the reduction and management of violence risk (and therefore inherent within 
this idea, improvement in social functioning), there is currently still little in the way of 
interventions available which fulfil this need.  At the turn of the century,  Bloom, Mueser 
and Müller-Isberner (2000) concluded that although, as yet, there was a lack of specific 
evidence-based literature on the treatment of violence amongst mentally disordered 
offenders (including those with schizophrenia), the required components had been 
identified that could produce an effective approach to treatment.  However, more than a 
decade later, and it appears as though we are still searching for an effective approach to 
psychosocial treatment. 
 
Therefore, it appears that there would be a clear benefit to exploring patterns of 
metacognitive ability in people with schizophrenia who have a history of interpersonal 
violence.  This would be important not only to further develop our knowledge and 
understanding of the nuances of metacognition in schizophrenia, but also as it may 
contribute towards the development of targeted interventions that could be matched to the 
pattern of metacognitive functioning evident in those with a history of interpersonal 
violence.  To the author’s knowledge, metacognition has not been investigated before in 
relation to violence in schizophrenia.  The current study will do this by exploring patterns of 
metacognitive ability through narratives of self, in a sample of forensic patients with 
schizophrenia who have a history of interpersonal violence.  The findings will be compared 
with a sample of individuals with schizophrenia who have no history of interpersonal 
violence, and who are being treated in the community.  This will allow for observations to 
be made regarding any differences in metacognitive ability present between these two 
groups.  
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Research Aims, Questions and Hypotheses 
 
This study aims to address the following research questions: 
 
1. How does metacognitive ability in a forensic population of people with schizophrenia 
and a history of interpersonal violence compare to people with schizophrenia who 
have no history of interpersonal violence, and who are being treated in the 
community? 
 
2. What patterns of metacognitive ability exist in people with schizophrenia and a 
history of interpersonal violence who are being treated by forensic services? 
 
The following hypotheses will be explored: 
 
Hypothesis 1: The forensic group will show differences of ability in each of the three 
domains of metacognition measured, relative to the community psychosis group (i.e., 
metacognitive ability will show between-group differences).  
 
Hypothesis 2: Differences in ability will exist between the three different domains of 
metacognitive functioning in a forensic population of people with schizophrenia who have a 
history of interpersonal violence (i.e. for the forensic group metacognitive ability will show 
within-group differences across the three domains).  
 
 
Method 
 
Participants 
 
Two groups of participants were recruited for the present study: a forensic group and a 
psychosis comparator group.  Participants in the ‘Forensic’ group were receiving treatment 
from forensic mental health services, and were recruited from a medium-secure hospital, a 
low-secure hospital, and two Forensic Community Mental Health Teams.  To be included in 
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this group participants had to be aged between 18-64; have a primary diagnosis of 
schizophrenia (or similar); and have a history of interpersonal violence as defined by the 
HCR-20 (Webster et al., 1997): actual, threatened or attempted harm towards others.  Being 
managed within forensic services implied the history of interpersonal violence was at a level 
that presented a significant risk of harm to self and/or others.   
 
The ‘Psychosis’ group were recruited from Community Mental Health Teams where they 
were currently receiving treatment.  For inclusion in this group, participants had to be aged 
between 18-64; have a primary diagnosis of schizophrenia (or similar); and have no history 
of interpersonal violence. 
 
Individuals who were acutely psychotic, had a diagnosis of autistic spectrum disorder or 
were identified as having a learning disability were excluded from participating in the study.  
Furthermore, people who had a history of organic or acquired brain injury were unable to 
participate, as were those who did not have English as their first language, due to the use of 
narrative data. 
 
Participants in the ‘Forensic’ group were recruited by the author by approaching the 
appropriate clinical teams who then identified potentially suitable participants to take part.  
These individuals were then provided with information on the study (Appendix 2.1) and 
were able to “opt in” and notify their interest (Appendix 2.2).  During an initial meeting with 
the author to discuss participation in the study, written and informed consent was taken 
(Appendix 2.3).  As the current study formed part of a wider collaborative study with two 
other researchers (Dr Angus MacBeth – AM; and Ms Elizabeth Reilly – ER), participants in 
the ‘Psychosis’ group were recruited using similar methods by a second researcher (AM).   
 
Measures 
 
Narrative Interview for Compassion and Recovery (NICR) 
The NICR (MacBeth & Gumley, 2011) is a semi-structured interview that explores stress and 
coping with participants, including their sources of support during these times and 
strategies they used to manage interpersonal conflict (Appendix 2.4).  So that it was suitable 
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for the purpose of assessing metacognitive ability, it allowed participants the opportunity to 
“think about their own thinking, the thinking of others and the problems they are 
presented, without posing direct problems to be solved” (Lysaker et al., 2005, p.65).  As the 
NICR was being used for the first time in the present study, and by two other researchers 
(AM and ER) in two other simultaneous studies, careful consideration was given to the use 
and administration of the interview.  This involved training and supervision with the creators 
of the NICR, the author, and researcher ER who would also be using it.  Transcripts of the 
NICR from these first three studies (including the one reported here) will be made available 
in order to calculate inter-reliability on the use of the interview.       
 
Metacognitive Assessment Scale (Revised Edition) (MAS-R) 
The MAS-R (Carcione et al., 2010; available from the authors on request) is a tool that can 
be applied to narrative transcripts to measure metacognitive ability (revised from an earlier 
version; Semerari et al., 2003).  In addition to looking at metacognition as a whole, it can 
also provide a measure of different domains of metacognition.  In order to do this the MAS-
R uses 3 sub-scales: Understanding of One’s Own Mind (UM); Understanding of Other’s 
Mind (UOM); and Mastery (M), which each comprise different sub-functions, to build up a 
profile of an individual’s metacognitive abilities.  Using the MAS-R rating scale (Appendix 
2.5), for each sub-function points can be awarded by the rater using a Likert-type scale of 0-
5 (‘not engaged’ – ‘sophisticated’) according to the level of metacognitive skills evident in 
the narrative.  These can then be summed to yield a measure of metacognitive ability, 
overall or at the sub-scale/domain level.  Scores on the three sub-scales measured (UM; 
UOM; and M) can range from 0-40; 0-25; and 0-40 respectively.  The Principal Investigator 
who was trained in the use of the MAS-R provided training and supervision to the author in 
the use of this tool.  Consultation from the tool’s creators was also provided in order to 
ensure proper and reliable use.  As this was the first time that the MAS-R had been used in 
empirical group research, no normative or comparative data is available at present for 
clinical populations similar to the ones included in the current study.  However, in order to 
measure inter-rater reliability for the MAS-R, a sample of 6 transcripts was coded by both 
the author and another researcher (ER) trained to use the tool.  An analysis using the Kappa 
statistic was performed to determine consistency between the two raters.  The outcome of 
this analysis was κ = 0.93, p< .001, which is classified as “outstanding” inter-rater reliability.  
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Furthermore, the same 6 transcripts were coded by one of the authors of the MAS-R.  In 
terms of inter-rater reliability, significant Pearson correlations were reported for ratings of 
the UM (r = 0.95, p< 0.05); UOM (r = 1.00, p< 0.001); and M (r = 0.97, p< 0.01) sub-scales.      
 
 Brief Symptom Inventory (BSI) 
The BSI (Derogatis, 1993) is a self-report measure that aims at identifying psychological 
symptoms of clinical significance.  The 53-item measure looks at 9 symptom classes 
including depression, anxiety and paranoid ideation.  Further to this, it can yield overall 
measures of current and past symptom levels, symptom intensity and total number of 
symptoms.  Higher scores indicate greater levels of psychopathology.  Convergent validity, 
test re-test reliability and internal consistency have been reported as ‘very good’ (Derogatis 
& Melisaratos, 1983).   
 
The Positive and Negative Syndrome Scale (PANSS) 
The PANSS (Kay, Fiszbein, & Opler, 1987) is a scale comprising 30 items that allows ratings to 
be made on a range of symptoms associated with severe mental health problems.  The scale 
is divided into 3 sub-scales that allow for separate analysis of positive and negative 
symptoms, and general psychopathology.  Increasing scores reflect greater levels of 
psychopathology.  Inter-rater reliability is reported as α = 0.80 (Kay, Opler, & Lidenmayer, 
1987).    
 
HCR-20 
The HCR-20 (Webster et al., 1997) is a structured clinical assessment tool, which aids clinical 
judgement on risk of future interpersonal violence.  It comprises 20 items, which are 
classified under 3 sub-scale headings: historical (10 items), clinical (5 items) and risk-
management (5 items) (Table 1).  Each item can be scored 0-2 (0 = no evidence; 1 = partially 
present; 2 = definite evidence) accordingly.  The total score for the HCR-20 can range from 
0-40.  The total scores for the Historical, Clinical and Risk Management sub-scales range 
from 0-20; 0-10; and 0-10 respectively.  Although in clinical practice the HCR-20 is used 
within a qualitative framework, it can be used quantitatively for research purposes, with 
increasing scores representing increasing risk of future violence.  Inter-rater reliability for 
the HCR-20 has been described as ‘very good’ (Belfrage, 1998). 
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INSERT TABLE 1 HERE 
          
 
 
Research Procedures 
 
For the ‘Forensic’ group, the author completed the study with each participant across two 
separate sessions lasting approximately 1 hour each.  During the first session participants 
took part in the semi-structured interview.  At the second session participants completed 
the self-report measure and the author administered the PANSS.  Participants were then 
debriefed (Appendix 2.6).  Researcher AM followed these procedures with the ‘Psychosis’ 
group, first interviewing participants and then meeting with them to administer the PANSS 
and complete the self-report measure.  For the ‘Forensic’ group, between the two sessions 
the author accessed the NHS mental health files of participants in order to score the HCR-20 
and record diagnostic information. 
 
Interviews for the ‘Forensic’ group were then transcribed by the author, while the 
interviews from the ‘Psychosis’ group were transcribed by researcher AM.  The author then 
used the MAS-R to code the narrative data from the transcripts for the ‘Forensic’ group and 
6 transcripts for the ‘Psychosis’ group.  Researcher ER used the MAS-R to code the 5 
remaining transcripts for this group.   
 
Statistical Analysis 
 
As there was little research available that addressed the aims described earlier, this was an 
exploratory study, and as such it was not possible to perform appropriate a-priori power 
calculations to inform sample size.  Therefore, the author sought to explore the effect sizes 
observed in tests of assumption and tests of difference as a direct outcome of this study in 
order to inform future research.   
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Statistical Package for Social Sciences (SPSS) v.18 was used for data entry and analysis.  A-
priori, Kolmogorov-Smirnov and Levine’s tests were performed in order to investigate the 
assumptions of normality and homogeneity of variance respectively for the data.  The 
outcomes from this analysis then guided the selection of the appropriate parametric or non-
parametric equivalent tests to answer the research questions.  Both descriptive and 
inferential statistics were used to explore within- and between-group data, and included 
analysis of variance (ANOVA), correlations, and tests for the comparison of two means.  
Post-hoc analyses were then performed on the data using the appropriate parametric or 
non-parametric tests.   
 
Ethics 
 
Ethical approval for the study was granted by the NHS West of Scotland Research Ethics 
Committee (REC reference number: 10/S0703/67) (Appendix 2.7).  Further approval was 
also obtained from the NHS Greater Glasgow & Clyde (GG&C) Research and Development 
committee (Appendix 2.8), and the NHS GG&C Directorate of Forensic Mental Health and 
Learning Disability research and audit committee.   
 
 
Results 
 
Participant Characteristics 
 
For the ‘Forensic’ group, 27 people in total were approached to take part in the study.  Eight 
individuals declined to continue any further after the first meeting with the author and one 
individual was not accepted into the study as they did not meet the criteria, leaving n=18 
remaining.  After consent was taken the drop-out rate was 0% for the interview stage, 
although 1 participant (6%) did not return to complete the self-report measures.  For the 
‘Psychosis’ group 21 people in total were approached to take part.  Ten individuals did not 
consent to participation, therefore n=11 took part in the study.  Once consent was taken the 
drop-out rate was 0%.    
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The main demographic characteristics of the two groups are presented in Table 2.  
Comparisons between the two groups showed that there were significant differences on 
some demographic characteristics.  Specifically, Chi-square analysis showed that there was a 
significant difference between the groups (‘Forensic’ and ‘Psychosis’) for gender, as the 
‘Forensic’ group consisted only of males and the ‘Psychosis’ group contained females.  There 
was also a significant between-group difference for education, with the ‘Psychosis’ group 
receiving more education.   
 
 
          
INSERT TABLE 2 HERE 
          
 
 
Table 3 shows the main clinical characteristics of the two groups.  Mann-Whitney tests 
showed that there were differences between several variables.  The ‘Psychosis’ group 
scored significantly higher on the PANSS positive and general psychopathology sub-scales.  
Furthermore, significant differences were evident on the majority of sub-scales in the BSI.  
Again, the ‘Psychosis’ group showed the significantly higher scores on the Obsessive-
Compulsive; Interpersonal Sensitivity; Depression; Anxiety; Phobic Anxiety; Paranoid 
Ideation; and Psychoticism subscales.     
  
 
          
INSERT TABLE 3 HERE 
          
 
 
Metacognition  
 
A-priori the MAS data were explored in order to identify potential covariates that could 
affect the validity of the analysis.  Kendall’s tau correlations were performed to look at the 
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relationship between scores on the MAS with age; education; PANSS scores; and BSI scores 
across the two groups.  Significant relationships were found to exist between the MAS with 
education and PANSS negative sub-scale scores.  This showed that education was 
significantly correlated with the ‘Understanding Others’ Mind’ sub-scale.  The analysis also 
showed that PANSS negative scores were significantly correlated with the ‘Understanding 
own Mind’; ‘Understanding Others’ Mind’; and ‘Mastery’ sub-scales; and MAS total score.  
The findings of the correlations are presented in Table 4.   
 
 
          
INSERT TABLE 4 HERE 
          
 
 
The median scores obtained for both the ‘Forensic’ and ‘Psychosis’ groups on the MAS are 
presented in Table 5.  Mann-Whitney tests were performed to investigate the differences 
between the groups on the MAS.  Although Table 5 shows there is a trend for the ‘Psychosis’ 
group to have scored higher on all three sub-scales on the MAS, and on the total score for 
metacognitive ability, statistical analysis showed that there were no significant differences 
between the groups on the ‘Understanding own Mind’; ‘Understanding Other’s Mind’; and 
‘Mastery’ sub-scales; or on total MAS score.  Therefore, it was not necessary to transform 
the data in order to perform an Analysis of Covariance (ANCOVA) to control for the effects 
of PANSS negative sub-scale scores and education. 
 
 
          
INSERT TABLE 5 HERE 
          
 
 
In order to further explore the pattern of metacognitive ability in the ‘Forensic’ group, the 
mean item score for each MAS sub-scale was calculated.  A Friedman’s ANOVA was then 
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selected to determine whether there were any significant differences between the sub-
scales on mean item scores.  The results showed that there were significant differences 
between the three sub-scales in terms of mean score awarded in each scale (χ
2
 (2) = 27.80, 
p< .001).  Wilcoxon Signed Ranks Test post-hoc comparisons indicated that mean item 
scores on the ‘Understanding own Mind’ sub-scale was significantly higher than those on 
the ‘Understanding Others’ Mind’ sub-scale (z = -3.24, p< .001, r =- 0.44) and ‘Mastery’ sub-
scale (z = -3.73, p < .001, r = -0.51 ).  Furthermore, the results indicated that mean item 
scores on the ‘Understanding Others’ Mind’ sub-scale were significantly higher than those 
on the ‘Mastery’ subscale (z = -3.57, p< .001, r = -0.49).  A similar result was found for the 
‘Psychosis’ group, with the indication that there was a significant difference between the 
sub-scales on mean item scores (χ
2 
(2) = 18.73, p< .001).  However, Wilcoxon Signed Ranks 
Test post-hoc comparisons showed that significance levels were lower when considering 
that mean item scores on the ‘Understanding own Mind’ sub-scale were significantly higher 
than the ‘Understanding Others’ Mind’ subscale (z = -2.94, p = .001, r = -0.51) and ‘Mastery’ 
sub-scale (z = -2.95, p = .001, r = -0.51), and also that the mean item scores on the 
‘Understanding Others’ Mind’ sub-scale were in turn significantly higher than the ‘Mastery’ 
sub-scale (z = -2.49, p = .010, r = -0.43).    
 
Post-Hoc Analyses 
 
Kendall’s tau correlations were repeated for the ‘Forensic’ group.  The pattern of 
correlations remained relatively stable, with again significant relationships being found 
between PANSS negative sub-scale scores and the MAS subscales in addition to the total 
MAS scores.  Correlation coefficients were similar to those reported across the two groups: 
‘Understanding own Mind’ (τ = -0.50, p< 0.01); ‘Understanding Others’ Mind’ (τ = -0.52, p< 
0.01); ‘Mastery’ (τ = -0.47, p< 0.05); MAS total score (τ = -0.52, p< 0.01).  Furthermore, a 
significant relationship was again found between education and ‘Understanding Others’ 
Mind’ sub-scale scores (τ = 0.39, p< 0.05), but in addition there was also evidence of a 
significant correlation between education and ‘Mastery’ sub-scale scores (τ = 0.39, p< 0.05). 
 
In order to investigate whether having a secondary diagnosis of personality disorder in the 
‘Forensic’ group had an effect on metacognitive ability, the data were analysed to 
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determine whether there were any differences on MAS scores between those with a 
Personality Disorder (PD) diagnosis (n = 7 Anti-social PD; n = 1 Psychopathic PD) and those 
without.  Again, Mann-Whitney tests were used to investigate any between-group 
differences.  They showed that there was no difference between those who did or did not 
have a secondary diagnosis of PD on the ‘Understanding own Mind’ (U = 40.00, p = NS, r = 
0); ‘Understanding Others’ Mind’ (U = 33.00, P = NS, r = -0.15); and ‘Mastery’ (U = 39.50, p = 
NS, -0.01) sub-scales; or on MAS total score (U = 39.50, p = NS, r = -0.01).  Therefore again it 
was not necessary to transform the data and perform an ANCOVA to control for the effects 
of PANSS negative scale scores and education.   
 
A further post-hoc analysis looked at whether metacognitive ability was related to risk of 
future violence, and therefore a Kendall’s tau correlation was used to analyse the 
relationship between scores on the MAS and the HCR-20.  No significant correlation was 
found between the HCR-20 and ‘Understanding own Mind’ (τ = 0.09, p = NS); 
‘Understanding Others’ Mind’ (τ = -0.03, p = NS); or ‘Mastery’ (τ = 0.01, p = NS) sub-scales; 
or the total MAS scores (τ = 0.07, p = NS).  
 
 
Discussion 
 
Main Findings 
 
This was an exploratory study which aimed at investigating two questions.  Firstly, the study 
asked how metacognitive ability in people with schizophrenia and a history of interpersonal 
violence might compare to people with schizophrenia with no history of violence.  Related 
to this question it was hypothesised that the ‘Forensic’ group would show differences in 
metacognitive ability across the three domains measured relative to the community 
‘Psychosis’ group.  This prediction was not supported by the findings of the study.    
  
Secondly, the study asked what patterns of metacognitive ability exist in people with 
schizophrenia who have a history of interpersonal violence and are treated within forensic 
mental health services.  Specifically, it was predicted that differences would exist between 
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the different domains of metacognitive functioning measured.  The evidence supported this 
prediction, as the findings suggested there were significant within-group differences 
between the three domains of metacognition measured by the MAS-R, with ‘understanding 
own mind’ being more sophisticated than ‘understanding others’ mind’, which were both in 
turn better than the ability to put this information together to solve problems (‘mastery’).  
 
Previous Literature 
 
Taken together these findings show some consistencies with the previous literature, but 
also highlight some interesting and surprising findings.  Unexpectedly, although scores on 
the MAS-R sub-scales were consistently higher for the ‘Psychosis’ group, no significant 
differences were found between the two groups in terms of metacognitive ability.  These 
findings are interesting, as although the issue of violence in people with schizophrenia is 
undoubtedly complex (Walsh, Buchanan, & Fahy, 2002), one may expect, based on the 
evidence highlighting the role metacognition may play in outcomes and symptom 
expression (Lysaker et al., 2011b), that in a group of people with schizophrenia, those who 
have used interpersonal violence to resolve problems may show a difference in 
metacognitive ability from those that have not.  In line with this it may also be expected that 
metacognition and risk of interpersonal violence would therefore be associated with one 
another, which the findings again did not support.  Furthermore, these findings are 
inconsistent with those reported by Levinson and Fonagy (2004) who investigated the 
relationship between offending and reflective functioning (RF), which is theoretically related 
to mentalization, and is defined as the ability to recognise and define mental processes in 
the self and in others (Fonagy, Target, Steele, & Steele, 1998).  They found that RF capacity 
was significantly lower in their sample of psychiatric-disordered offenders than in their non-
offending personality disorder comparison group.  In addition, when comparing offenders 
who had committed violent or non-violent crimes, the violent offending group showed 
significantly lower RF ability, and moreover, 93% could be categorised as having ‘low’ RF, 
compared to 29% of the non-violent offenders.   
 
Another interesting finding emerged from the observation of metacognitive ability between 
those who had a diagnosis of Anti-social or Psychopathic PD, and those who had no PD 
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diagnosis in the ‘Forensic’ group.  The existing literature on PD and metacognition suggests 
that people with different PD diagnoses (e.g., narcissistic, borderline, or avoidant) show 
different patterns of metacognitive impairment from one another (Dimaggio, Semerari, 
Carcione, Nicolò, & Procacci, 2007), and thus PD diagnosis is related to metacognition.  
Inconsistent with this, the evidence from this study suggests that a secondary diagnosis of 
PD is not associated with a different pattern of metacognitive ability. However, this finding 
should be interpreted with caution as many of the participants, although not deemed as 
meeting the criteria for PD, had significant anti-social and psychopathic personality traits. 
 
Although there are no standardised data for the MAS-R, and this study was not looking 
specifically at the degree of impairment of metacognition relative to a healthy control 
group, closer inspection of the data suggests that in line with the literature (e.g., Levinson & 
Fonagy, 2004; Lysaker et al., 2005), both groups showed an overall impairment in 
metacognitive function.  The mean individual item data showed that in both groups, the 
presence and use of metacognitive abilities was rated within the ‘scarce’ to ‘moderate’ 
range, and did not reach classifications of ‘good’ or ‘sophisticated’.  Therefore, although 
there were no significant differences between the two groups, both showed difficulty with 
metacognitive functioning, which in line with the findings reported above, does not seem 
specific to interpersonal violence or PD diagnosis.  However, the presence of negative 
symptoms was significantly related to metacognitive ability with increasing PANSS negative 
scores being associated with decreasing metacognitive ability.  Although the cross-sectional 
design of this study precludes one from drawing conclusions about the direction of 
causality, these findings support others that advocate for the presence of a relationship 
between negative symptoms and metacognitive functioning.  For example, this finding is 
consistent with those reported by Greig, Bryson and Bell (2004) who found that increasing 
levels of negative symptoms in people with schizophrenia was associated with greater 
impairment on ToM tasks, while emotional withdrawal has been shown to be inversely 
related to the three domains of metacognition measured by the MAS (Lysaker et al., 2005).  
Furthermore, individuals with schizophrenia spectrum disorders who had impairments in 
both being able to recognise one’s own and other’s emotional states have been shown to 
have significantly higher levels of negative symptoms than those who did not have impaired 
emotion awareness (Lysaker et al., in press).  Taken together, these findings may suggest 
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that the presence of negative symptoms indicate metacognitive impairments, which may 
need to be addressed if there is to be an improvement in symptom expression. 
 
The findings that addressed the second hypothesis add further support to the idea of 
metacognitive ability being a modular construct, and comprising semi-independent 
functions which work both together and independently of one another (e.g., Bosco et al., 
2009; Dimaggio et al., 2009).  Specifically, the pattern of metacognition measured by the 
MAS-R for both groups showed that some domains (and sub-domains) appeared to be less 
sophisticated than others, suggesting different aspects of metacognition can be 
differentially impaired.  In particular the ability to represent and think about own mental 
states was more sophisticated than the ability to represent and think about others’ mental 
states, which in turn were both more developed than the ability to integrate this mental 
state information to solve problems.  This ‘hierarchical’ pattern of metacognitive ability is 
consistent with other findings (e.g., Lysaker, Buck, & Ringer, 2007a) whereby it is proposed 
that being able to first recognise and interpret one’s own mental states will have a strong 
influence on the development of being able to solve problems using mental state 
information and being able to understand and interpret the mental state of others.  This is 
consistent with the developmental underpinnings of mentalization (Bateman & Fonagy, 
2004) which assert that a secure early attachment relationship will allow an infant to 
develop an awareness of their own internal states, from which more complex and organised 
representations can then be produced (Choi-Kain & Gunderson, 2008).  However, of note 
the present study found that the ability to understand others’ mental states was more 
sophisticated than ‘Mastery’ skills, whereas other studies have reported the opposite (e.g., 
Lysaker et al., 2007a; Lysaker et al., 2005).      
 
Limitations 
 
There were several limitations in this study that warrant further discussion.  Firstly, due to 
the small sample size, the statistical tests of difference performed may have been under-
powered, and thus, if significant differences did exist between the variables under 
investigation they may not have been detected.  Therefore future studies in this area should 
use a larger sample size. 
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There were also some methodological limitations in this study.  The nature of the interview 
meant metacognition was assessed within a relatively stable context.  Recent evidence 
suggests that mentalization ability is influenced by many factors including motivation to 
investigate mental states, internal feelings of threat and safety, and the social role one is 
currently engaged in (Liotti & Gilbert, 2011).  Therefore, the way metacognition unfolded in 
the interview scenario during the research may be different to how it would unfold during 
other interview scenarios, or during real-life situations whereby one feels there is an 
immediate threat to their personal safety, and thus generalisability of the findings is limited.   
 
Finally, the two groups in the study were different in many respects, for example, significant 
differences were reported on several clinical characteristics and factors such as gender and 
level of education.  Whilst recognising that this study did not utilise a matched-control 
design, these differences between the two groups could have had implications for the 
findings reported.  These differences were in part due to the nature of the participants in 
the ‘Forensic’ group who were mostly long-stay patients in secure hospitals who had 
responded well to treatment, and thus their mental health was relatively stable.  This could 
have had further implications for the findings in this study, as although the risk of future 
violence for the ‘Forensic’ group was comparable to that reported for similar groups in 
other studies (e.g., Belfrage, 1998)  for many their ‘history of interpersonal violence’ was 
indeed historical, with the last episode having occurred several years ago.  Thus in future, 
comparisons may be better made between groups who are more similar in clinical 
characteristics, and where violence is in greater proximity to assessment of metacognition.  
This may be achieved by recruiting ‘Forensic’ participants from admissions wards rather 
than rehabilitation wards.  Furthermore, given this limitation of the ‘Forensic’ sample 
recruited, and the small effect sizes reported for tests of difference between the two 
groups, this study may not be the most appropriate to inform a-priori power, and sample 
size calculations.       
 
Clinical Implications of Research 
 
The findings of this study can generate some useful suggestions for intervention in people 
with schizophrenia who have a history of interpersonal violence.  Previous research 
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attempting to address the treatment of violence in people within this diagnostic category 
has been scarce, and that which has been done has demonstrated little advantage for 
different interventions.  For example, Haddock et al. (2009) carried out a randomised 
controlled trial to assess the effectiveness of cognitive-behavioural therapy (CBT) on 
violence, anger and psychosis in people with a diagnosis of schizophrenia that had a history 
of violence.  Compared to a social activity therapy group, those in the CBT group showed 
little advantage in terms of a reduction in violence or aggression.  The findings of this study 
support the suggestion that metacognitive capacity and specific weaknesses should be 
taken into consideration when undertaking any psychotherapeutic work (Dimaggio et al., 
2011), and thus interventions such as CBT and problem-solving based therapies take for 
granted that the patient has the capacity for these skills.  Therefore, as the results of this 
study and others suggest that metacognitive ability forms a hierarchy, with some domains 
of metacognition being more impaired than others (e.g., Lysaker et al., 2007a), therapists 
should begin by initially assessing and developing an individual’s ability to represent and 
recognise their own mental states.  The MAS-R (or MAS) may be a useful tool to do this 
within a therapeutic setting (Buck & Lysaker, 2009).  Following this, the process can be 
replicated for the ability to recognise and interpret others’ mental states, before targeting 
interventions that support individuals to integrate mental state information to resolve 
problems (i.e., ‘Mastery’ skills).  Finally, once these skills are present, one can then perhaps 
make better use of psychotherapies that assume these abilities are functioning (e.g., CBT).  
Lysaker et al. (2011a) have recently begun to develop a model that explains how the 
assessment and development of the ability to think about our own thinking may be 
achieved in psychotherapy sessions.   
 
Future Research Directions 
 
This was an exploratory study and as such the sample size was quite small.  Therefore future 
research in this area should use larger sample sizes, in order to increase the power of 
statistical tests.  Furthermore, metacognitive ability should be investigated over time in 
people with schizophrenia and a history of interpersonal violence, with a focus on different 
clinical correlates such as negative symptoms, so as to allow for a more detailed pattern of 
metacognitive ability in this population to be developed and understood.  Furthermore, it 
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should also be a priority to recruit participants who are currently violent in order to ensure 
greater validity.  In addition, more research is required into how metacognitive abilities may 
be developed over time so that individuals may perhaps derive optimum benefit from 
psychotherapeutic interventions.     
 
Conclusions 
 
Overall, this study highlights the similarities in the quality of metacognitive functioning, and 
the patterns of metacognitive ability, between people with schizophrenia who do or do not 
have a history of interpersonal violence.  Specifically both groups showed that their ability 
to think about their own mental states is the strongest, followed by their ability to think 
about the mental states of others, and finally the ability to integrate this information to 
solve problems is the weakest.  This adds to our knowledge of the nuances of patterns of 
metacognitive ability amongst this diagnostic group, and suggests that although 
metacognition may be related to several outcomes common to those with schizophrenia, it 
does not appear that a specific difference in metacognitive ability is related to violence as an 
outcome.  However, as metacognitive ability was consistently stronger amongst those 
without a history of violence, it might be helpful to continue to investigate this issue with 
more participants in order to allow for greater power of statistical tests to detect 
differences between the groups, and with a ‘Forensic’ group who are actively violent.         
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Table 1. Items rated in the HCR-20. 
 
Historical (Past) Items Clinical (Present) Items Risk Management (Future) 
Items 
H1 Previous violence 
 
H2 Young age at first violent   
       incident 
 
H3 Relationship instability 
 
H4 Employment problems 
 
H5 Substance use problems 
 
H6 Major mental illness 
 
H7 Psychopathy 
 
H8 Early maladjustment 
 
H9 Personality disorder 
 
H10 Prior supervision failure 
C1 Lack of insight 
 
C2 Negative attitudes 
 
C3 Active symptoms of major 
mental illness 
 
C4 Impulsivity 
 
C5 Unresponsive to  
      treatment 
R1 Plans lack feasibility 
 
R2 Exposure to destabilisers 
 
R3 Lack of personal support 
 
R4 Noncompliance with  
      remediation attempts 
 
R5 Stress 
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Table 2. Demographic characteristics of participants 
 
Variable Forensic Group 
n = 18 
Psychosis Group 
n = 11 
Test of 
difference (t/ Χ
2
) 
ES 
    
Age in Years, mean (SD) 40.50 (10.42) 41.00 (9.51) t(27) = -0.13, 
r = 0.02 
    
Gender 
Male  
Female 
 
18 
0 
 
7 
4 
χ
2
(1) = 7.59*, 
phi = 0.51 
    
Ethnic Group 
White Scottish 
Other 
 
17 
1 
 
10 
1 
χ
2
(1) = 0.13, 
phi = 0.07 
    
Marital Status 
Single 
Married 
Separated/Divorced 
 
12 
2 
4 
 
8 
1 
2 
χ
2
(2) = 0.12, 
Cramer’s V = 0.06 
    
Education 
Left school before 16/no qualifications 
Standard Grades/O Levels 
Highers or equivalent 
College or equivalent 
University 
Not available 
 
11 
3 
2 
2 
0 
0 
 
2 
2 
0 
4 
2 
1 
χ
2 
= 11.05*, 
Cramer’s V = 0.62 
 
 
*p < .05; ES, effect size 
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Table 3. Clinical characteristics of participants   
 
Variable Forensic Group 
n = 18 
Psychosis Group 
n = 11 
Test of Difference 
(t/U/ χ
2)
, ES 
    
Primary Diagnosis 
Schizophrenia 
Schizoaffective Disorder 
Unspecified Non-Organic Psychosis 
Persistent Delusional Disorder 
 
18 
2 
0 
0 
 
7 
2 
1 
1 
Χ
2
(3) = 4.07, 
Cramer’s V = 0.38 
    
Years since Diagnosis, mean (SD) 14.33 (5.48) 10.00 (7.10) t(26) = -1.80, r = 0.33 
    
PANSS, median (IQR)  
Positive symptoms 
Negative symptoms 
General psychopathology 
 
9.50 (4) 
12.50 (9) 
20.00 (6) 
 
15.00 (6) 
15.00 (8) 
35.00 (13) 
 
U = 39.00**, r = -.051 
U = 86.00, r = -0.11 
U = 34.00**, r = -0.54 
    
BSI, median (IQR) 
Somatization 
Obsessive-Compulsive 
Interpersonal Sensitivity 
Depression 
Anxiety 
Hostility 
Phobic anxiety 
Paranoid Ideation 
Psychoticism 
 
0.86 (1.21) 
0.50 (1.33) 
0.25 (1.50) 
0.33 (1.17) 
0.17 (1.42) 
0.00 (0.40) 
0.00 (0.80) 
0.00 (0.90) 
0.20 (1.50) 
 
0.57 (1.00) 
1.67 (1.17) 
1.75 (1.50) 
1.67 (1.33) 
1.67 (1.84) 
0.60 (0.80) 
1.20 (2.00) 
1.80 (2.00) 
1.60 (1.40) 
 
U = 84.50, r = -0.08 
U = 31.00**, r = -0.55 
U = 38.50**, r = -0.49 
U = 33.50**, r = -0.53 
U = 40.50*, r = -0.47 
U = 62.50, r = -0.29 
U = 32.00**, r = -0.55 
U = 31.00**, r = -0.56 
U = 45.00*, r = -0.43 
    
HCR-20, mean (SD) 
Historical 
Clinical 
Risk Management 
Total 
 
15.61 (2.91) 
3.28 (2.34) 
4.28 (2.56) 
23.17 (6.86) 
 
- 
- 
- 
- 
 
- 
- 
- 
- 
ES, effect size; IQR, Interquartile Range; PANSS, Positive and Negative Symptom Scale; BSI, Brief Symptom 
Inventory. 
* p< 0.05; ** p< 0.01  
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Table 4. Kendall’s tau (τ) correlations between scores on the MAS with demographic and  
               clinical outcomes. 
  
 Understanding 
own Mind (UM) 
Understanding 
Others’ Mind 
(UOM) 
Mastery (M) MAS total score 
Demographic Variables 
Age 
Education 
 
-0.03 
 0.29 
 
-0.03 
   0.33* 
 
-0.03 
 0.23 
 
-0.01 
 0.28 
     
PANSS 
Positive symptoms 
Negative symptoms 
General psychopathology 
 
-0.24 
       -0.53*** 
-0.26 
 
-0.18 
       -0.51*** 
-0.25 
 
-0.15 
     -0.44** 
-0.16 
 
-0.18 
       -0.52*** 
-0.22 
     
BSI 
Somatization 
Obsessive-Compulsive 
Interpersonal Sensitivity 
Depression 
Anxiety 
Hostility 
Phobic anxiety 
Paranoid Ideation 
Psychoticism 
 
Global Severity Index 
 
 0.07 
 0.05 
-0.04 
-0.01 
 0.06 
 0.18 
-0.10 
 0.00 
-0.03 
 
 0.05 
 
 0.03 
 0.11 
 0.07 
 0.05 
 0.09 
 0.18 
-0.05 
 0.13 
 0.06 
 
 0.09 
 
-0.05 
 0.00 
 0.01 
-0.02 
 0.02 
 0.14 
-0.02 
-0.01 
-0.03 
 
 0.03 
 
 0.03 
 0.05 
-0.01 
-0.03 
 0.06 
 0.16 
-0.09 
 0.03 
-0.03 
 
 0.03 
*p< .05; **p< .01; ***p< .001 
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Table 5. MAS score profiles with between-group and within group comparisons. 
 
 Forensic Group 
Median (IQR) 
Psychosis 
Group 
Median (IQR) 
Test of 
Difference (U, z) 
  ES 
‘Understanding Own Mind’ (UM) sub-functions 
Basic Requirements§ (1item; range: 0-5) 
Monitoring (3 items; range 0-15) 
Differentiation (2 items; range 0-10) 
Integration (2 items; range 0-10) 
 
‘UM’ SUB-SCALE TOTAL (range 0-40) 
 
 
Mean individual item score (range 0-5) 
 
3.00 (2) 
7.50 (6) 
5.00 (4) 
0.50 (4) 
 
16.00 (16) 
 
 
2.00 (2.03) 
 
3.00 (1) 
9.00 (3) 
5.00 (3) 
1.00 (3) 
 
18.00 (8) 
 
 
2.25 (1.00) 
 
- 
- 
- 
- 
 
U = 94.50
NS
, 
 z = -0.20, 
r = -0.04 
- 
    
‘Understanding Other’s Mind’ (UOM) sub-functions 
Monitoring (3 items; range 0-15) 
Decentration (1 item; range 0-5) 
 
‘UOM’ SUB-SCALE TOTAL (range 0-15) 
 
 
Mean individual item score (range 0-5) 
 
5.00 (2) 
1.00 (1) 
 
9.00 (3) 
 
 
1.80 (0.65) 
 
6.00 (4) 
1.00 (0) 
 
10.00 (5) 
 
 
2.00 (1.00) 
 
- 
- 
 
U = 84.50
NS
, 
z = -0.66, 
r = -0.12 
- 
    
‘Mastery’ (M) sub-functions 
Basic Requirements (1 item; range 0-5) 
1
st
 Level Strategies (2 items; range 0-10) 
2
nd
 Level Strategies (2 items; range 0-10) 
3
rd
 Level Strategies (3 items; range 0-10) 
 
‘MASTERY’ SUB-SCALE TOTAL (range 0-40) 
 
Mean individual item score (range 0-5) 
 
3.00 (1) 
2.50 (2) 
2.00 (1) 
1.00 (2) 
 
8.00 (7) 
 
1.00 (0.81) 
 
3.00 (0) 
4.00 (2) 
2.00 (2) 
0.00 (1) 
 
11.00 (3) 
 
1.38 (0.38) 
 
- 
- 
- 
- 
U = 85.50
NS
,  
z = -0.61, 
r = -0.11 
- 
    
METACOGNITION TOTAL SCORE 30.00 (26) 35.00 (17) U = 89.50
NS
, 
z = -0.43, 
r = -0.08 
§Basic Requirements scores are included in both ‘UM’ and ‘UOM’ mean sub-scale totals 
IQR, Interquartile Range; ES, effect size; 
NS
, not significant 
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Abstract 
 
This reflective account describes the challenges I encountered when working with a client in 
a community Older Adult service.  This is set within the context of my consideration of the 
need for the Clinical Psychology profession to justify its worth to services, which 
incorporates deliberation of the New Ways of Working (2007) policy.  The account will first 
guide the reader through what has influenced my decision to reflect on the issues at hand, 
before entering the main body of the account.  This is guided by psychodynamic principles, 
and aspects of Gibbs’ (1988) model of reflection and Rolfe et al’s (2001) framework for 
reflective practice.  From these I have provided a description of the situation, reflected upon 
my thoughts and feelings, and used this as a guide to consider an evaluation and analysis of 
the situation, as well as a conclusion to my reflections.  I have then presented a meta-
reflective account on my experience of this practice.         
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Page | 77  
 
Chapter 4 
 
 
Advanced Clinical Practice II Reflective Critical Account 
 
 
“Take me to your Leader”: An Alien Concept for Clinical Psychology 
or a Sign of Things to Come?  Reflecting on the Psychologist as 
Professional Lead  
 
 
Laura Jean Mitchell* 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Address for correspondence:  
Mental Health and Wellbeing 
Academic Centre 
Gartnavel Royal Hospital 
1055 Great Western Road 
Glasgow, G12 0XH 
Tel 0141 211 3927 
 
 
 
 
 
 
 
 
 
 
Submitted in partial fulfilment of the requirements for the degree of  
Doctorate in Clinical Psychology (DClinPsy) 
Page | 78  
 
Abstract 
 
The following reflective account portrays my consideration of the issues and challenges associated 
with Clinical Psychologists as Professional Leads in mental health services.  This is based upon my 
experience as a Trainee Clinical Psychologist within a Children and Young People’s Specialist Service 
which used this model of management, and contemplates the recommendations for the profession 
set by the New Ways of Working Project Group for Organising, Leading, and Managing Psychological 
Services.  The account will first consider why I have chosen to present this issue, before leading the 
reader to the main narrative of reflection.  This includes my thoughts on the areas of personal 
development that would be required for me to meet the challenges inherent in undertaking 
management roles.  Having previously found them to be helpful, the reflection is aided by 
consideration of two educational models for reflective practice: Gibbs’ (1988) model of reflection 
and Rolfe et al’s (2001) framework for reflective practice.  However, the account also reflects the 
free-floating flow of thoughts encouraged by psychoanalysis.  I conclude with a meta-reflection on 
my experiences of preparing the reflective account presented.         
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Appendix 1.2: Quality Criteria Rating Sheet 
 
Quality Criteria Rating Sheet: Positive Psychotic Symptoms and Violence Amongst People 
with Schizophrenia: A Systematic Review 
Author:  
Year:  
Title: 
 
 
Journal:  
Assessor:  
 
Topic Item Description Rating 
SAMPLING 1.1 The population and method of 
recruitment. 
Geographic cohort = 5 
Convenience sample = 2 
Highly selective sample (e.g. 
volunteers)  
OR  
not stated = 0 
 1.2 Were refusal/drop-out rates indicated? Yes = 1 
No = 0 
 1.3 Were analyses conducted comparing 
participants and those who refused to 
participate/dropped out? 
Yes = 1 
No = 0 
 1.4 Did it state whether participants were 
inpatients/outpatients? 
Yes = 1 
No = 0 
 1.5 Were diagnoses of participants reported? Yes = 1 
No = 0 
 1.6 Were the diagnostic criteria explicitly 
stated (e.g. DSM-IV, ICD-10)? 
Yes = 1 
No = 0 
 1.7 Were mean ages of participants reported? Yes = 1 
No = 0 
 1.8 Were genders of the participants 
reported? 
Yes = 1 
No = 0 
 1.9 Inclusion criteria explicitly stated? Yes = 1 
No = 0 
 1.10 Exclusion criteria explicitly stated?  
 
Yes = 1 
No/The study had no exclusion 
criteria = 0 
   Section worth 25%: Each item 
contributes 2.5% to the overall 
methodological value of the 
study. 
POSITIVE 
SYMPTOM AND 
COVARIATE 
ASSESSMENT 
2.1 Were positive symptoms assessed and 
reported with a reliable and valid 
measure? 
Yes = 1 
No = 0 
 2.2 Were positive symptoms examined 
separately (e.g. 
TCO/hallucinations/delusions)? 
Yes = 1 
No/Only one type of positive 
symptom was looked at = 0 
 2.3 Were negative symptoms assessed and 
reported with a reliable and valid 
measure? 
Yes = 1 
No/Not assessed = 0 
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 2.4 Was mood (e.g. depression/anxiety) 
assessed with a reliable and valid 
measure? 
Yes = 1 
No/Not assessed = 0 
 2.5 Was psychopathy assessed with a reliable 
and valid measure? 
Yes = 1 
No/Not assessed = 0 
 2.6 Was there an indication of who assessed 
patients i.e. their qualifications and 
training on measures?  
Yes = 1 
No/Self-report measures only = 
0 
 2.7 Were assessors blind to participants who 
had been violent? 
Yes = 1 
No/Not stated = 0 
 2.8 Was length of illness/total years in 
treatment reported? 
Yes = 1 
No = 0 
 2.9 Was the medication that participants were 
taking reported? 
Yes = 1 
No = 0 
 2.10 Were rates of substance dependency 
listed?  
Yes/Those with substance 
abuse disorder excluded = 1 
No = 0 
   Section worth 25%: Each item 
contributes 2.5% to the overall 
methodological value of the 
study. 
VIOLENCE 
ASSESSMENT 
3.1 Does the study describe how it defines 
violence towards others? 
Yes = 1 
No = 0 
 3.2 Was a standardised and validated measure 
used to assess violence? 
Yes = 1 
No = 0 
 3.3 Was information on violence gathered 
from more than one source of 
information? 
Yes = 1 
No/Not stated = 0 
 3.4 Was assessment of violence carried out 
longitudinally i.e. 2 or 3 different time 
points?  
Yes = 1 
No/Measure designed 
specifically to assess violence 
not used/Not stated = 0 
 3.5 Was the timing of the assessment of 
violence stated? 
Yes = 1 
No/Measure designed 
specifically to assess violence 
not used = 0 
 3.6 Was violence rated blind to knowledge of 
other variables e.g. psychopathy, positive 
symptoms, insight, etc.? 
Yes = 1 
No/Not stated/Not applicable = 
0 
 3.7 Were other forms of violence apart from 
physical harm towards others assessed? 
Yes = 1 
No = 0 
 3.8 Does the study describe how it defined 
other forms of violence? 
Yes = 1 
No/Not applicable = 0 
 3.9 Was the prevalence rate of violence clearly 
described? 
Yes = 1 
No = 0 
 3.10 Was violence history before the study 
period/lifetime violence rate reported? 
Yes = 1 
No = 0 
   Section worth 25%: Each item 
contributes 2.5% to the overall 
methodological value of the 
study. 
METHODOLOGY 
(DESIGN, POWER 
AND ANALYSIS 
4.1 What type of design was employed for the 
study?  
Prospective = 1 
Retrospective = 0 
 4.2 Were aims/hypothesis explicitly stated? Yes = 1 
No = 0 
Page | 85  
 
 4.3* Was this statistical power sufficient?  Yes = 1 
No/Not reported = 0 
 4.4 Was alpha modified in multiple statistical 
analyses to reduce the probability of type 
1 error? 
Yes/Not applicable/No 
correlation = 1 
No/Not discussed = 0 
 4.5 Were between group comparisons made 
between those who were/were not 
violent? 
Yes = 1 
No = 0 
 4.6 Were attempts made to match individuals 
who were/were not violent for between 
group comparisons (gender, time since 
diagnosis, etc.)? 
Yes = 1 
No/Not applicable = 0 
 4.7 Were attempts made to statistically 
control for confounding variables e.g. drug 
and alcohol misuse, length of time since 
diagnosis, etc.? 
Yes = 1 
No = 0 
   Section worth 25%: Each item 
contributes 2.5% to the overall 
methodological value of the 
study *except item 4.3 which is 
worth 10%. 
  Total: 
 
                         % 
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Appendix 2.1: Participant Information Sheet 
(Forensic Version) 
             (1 of 2 versions: Community Psychosis version) 
 
 
THINKING ABOUT RECOVERY PARTICIPANT 
INFORMATION SHEET 
 
             Invitation to Participate in a Research Project 
 
Title of the Project – Thinking about Recovery: The Importance of Reflection and Compassion in 
Understanding Individuals’ Recovery from Complex Mental Health Problems. 
 
What is the research about? 
This study is designed to investigate compassion and psychological reflection in people who have 
experienced complex mental health problems.  This kind of research will help mental health services 
to understand the needs of people who have experienced complex mental health problems, and to 
develop new psychological therapies that aim to help people recover.  The study is being undertaken 
as part of the fulfilment for an academic qualification (Doctorate in Clinical Psychology). 
 
Who is being asked to take part? 
We are asking people who have experienced complex mental health problems in the past to take part 
in the study. 
 
Why have I been asked to take part? 
A member of the mental health team responsible for your care (e.g. Consultant Psychiatrist, Clinical 
Psychologist or CPN) has suggested that you might be interested in participating in this study.  I am 
meeting with you to tell you a little more about what participating in the study would involve. 
 
What do you mean by the term ‘compassion’? 
By ‘compassion’, we mean a feeling of warmth, sympathy and caring that we can have about 
ourselves and others.   
 
What are you asking me to consent to? 
Consenting to participate in this study means that you will meet with a researcher on NHS premises 
three times and complete an interview and some questionnaires.  You will also be asked to consent to 
the researcher gaining access to your mental health file.  This will be to gather more important 
information for the study such as what treatment you have received to date.  This information will be 
treated in the strictest confidence (see below).  
 
What will I be asked to do if I agree to take part? 
The first meeting is an opportunity for you to ask questions about the study and discuss taking part.  
For your convenience, this will be arranged at a time when you are seeing a member of your clinical 
team anyway.  If you decide to participate, during the second meeting you will meet with the 
researcher to be interviewed.  During the interview, you will be asked about important relationships in 
your life and how you cope with stressful situations.  You will be asked to give a specific example of 
coping with a challenging time in your life.  This does not have to be something which has been very 
distressing for you and it is up to you which experiences you choose to discuss.  You will not be 
asked to disclose information about an index offence.  This meeting will last approximately 1 hour and 
the interview will be recorded.   
On the final visit you will be asked to fill in some questionnaires.  You will then be able to ask the 
researcher any questions you might have about your participation in the project. The time required for 
this meeting will vary, depending upon completion time of the questionnaires and any questions you 
may wish to ask, but will last approximately 30 minutes. 
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Will my information be confidential? 
All the information you provide, and file information, will be treated confidentially.  All recordings, 
transcriptions and other data will be stored in a password protected computer.  The interview will be 
fully-anonymised when it is transcribed by the researcher who interviews you.  This means that it will 
not include your name, the names of people, schools or jobs you may mention or any other 
information which could identify you.  Only the researcher who interviews you will hear the original 
transcript.  Once the interview is transcribed, the recorded audio copy will be destroyed.  The 
transcribed and anonymised interview and questionnaires will then be analysed by the research team.  
If you agree we may use quotations from conversations in reports about this research.  
 
If you share information that makes the research team concerned for your safety or the safety of other 
people, we may be required to tell others involved in your care (e.g. your key-worker or psychiatrist).  
We will always notify you beforehand if we are going to do this, and explain why.   
 
What happens to the consent form? 
To ensure anonymity and confidentiality, the consent form will be kept separately from the transcribed 
interview in a locked filing cabinet within the Section of Psychological Medicine. 
 
What are the benefits of taking part? 
In general, research improves our knowledge of what people’s difficulties are and what can do to help 
overcome these and improve people’s lives, so your participation will help increase our knowledge of 
areas and potentially improve treatment for others in the future.  
 
Is there a downside to taking part? 
As stated above, in the interview you will be asked to discuss how you coped with a challenging time 
in your life.  We do not expect you to be worried or distressed by your participation in the study.  
However, if you have any concerns about what we discussed, you can contact the researcher for 
more information or indeed discuss this further with your key-worker or member of your clinical team.  
Although we do not anticipate that participating in this study will cause you any distress, if this did 
happen we will help you to access appropriate support if needed.   
 
What happens if I decide not to take part? 
Nothing. Taking part is entirely up to you. If you do not wish to take part it will not affect any treatment 
that you currently receive. Also, if you do decide to take part, you are able to change your mind and 
withdraw from the study at any time without it affecting your care either now or in the future. 
 
After this meeting, the research team will give you at least 48 hours to decide whether you want to 
take part in the study.  If you still want to participate, then we will make arrangements to meet again.   
 
Can I change my mind?  
Yes. You can change your mind at any time and do not need to give a reason. Your care will not be 
affected in any way. 
 
What will happen to the results of the study? 
The results will be published in a medical journal and through other routes to ensure that the general 
public are also aware of the findings. You will not be identified in any report/publication arising from 
this study. 
 
Who is organising and funding the research? 
The University of Glasgow.  
 
Who has reviewed the study? 
The study has been reviewed by the University of Glasgow to ensure that it meets standards of 
scientific conduct.  It has also been reviewed by NHS Greater Glasgow & Clyde Mental Health Ethics 
Committee to ensure that it meets standards of ethical conduct.   
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Contact for Further Information 
If you have any questions you would like to ask, please do not hesitate to get in contact. 
 
Researcher     Chief Investigator 
Laura Mitchell                 Prof Andrew Gumley 
Trainee Clinical Psychologist    Professor in Clinical Psychology 
[ADDRESS]     [ADDRESS] 
Email xxxxxx@research.gla.ac.uk              Telephone Number: 0141 xxx xxxx 
Telephone Number: 0141 xxx xxxx 
 
Thank you for taking time to read this 
 
This has been approved by the NHS GG&C Ethics Committee 
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Appendix 2.2: Participant Opt-In Form – Forensic Inpatient Version 
(Version 1 of 3: forensic outpatient version; psychosis community version)   
 
 
 
THINKING ABOUT RECOVERY 
Invitation to Participate in a Research Project 
 
 
Laura Mitchell 
Trainee Clinical Psychologist 
[ADDRESS] 
 
Dear ______________ 
 
I am inviting you to participate in a research study called: ‘Thinking About Recovery’.  This 
project is separate to the care you are currently receiving, and participation is voluntary.  An 
information sheet about the study is attached to this letter.    
 
If you are interested in hearing more about the study, please complete the tear-off slip below 
and place it in the addressed envelope provided.  This can then be handed to a member of 
ward staff so it can be passed on to me.   
 
I can then arrange to meet with you to discuss the research in more detail.  Please be aware 
that you are welcome to withdraw from the study at any point without having to give a 
reason. 
 
Thank you for your time. 
 
Yours sincerely, 
 
 
Laura Mitchell 
Trainee Clinical Psychologist    
 
 
 
Name: ______________________________ [please print clearly] 
 
Hospital:_______________________  Ward: ____________________ 
 
Keyworker:___________________________ 
 
I am interested in meeting again to discuss my participation in the research project ‘Thinking 
About Recovery’. 
 
Signed: ________________________ 
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Appendix 2.3: Consent Form (Forensic Version) 
                  (Version 1 of 2: Psychosis community version) 
 
Invitation to Participate in a Research Project 
 
THINKING ABOUT RECOVERY 
 
Name of Participant: ……………………………………….   
 
 
Name of Researcher: ……………………………………... 
 
   
                                              Please Tick in the appropriate column:          YES          NO 
 
Have you read the information sheet?                                                         [       ]      [        ] 
 
Have you had opportunity to ask questions and to discuss the project?     [       ]      [        ] 
 
Have you received satisfactory answers to the questions?                         [       ]      [        ] 
 
Have you received enough information?                                                [       ]      [        ] 
 
Do you understand that you are free to withdraw your consent: 
 
at any time?                                                                                                 [       ]      [       ] 
 
without having to give a reason?                                                                 [       ]      [       ] 
 
and without affecting your future care?                                                        [       ]      [       ]    
Do you consent to take part in this research project?                [       ]      [       ] 
Do you consent to the researcher accessing your NHS file?   [       ]      [       ] 
Can we quote remarks you may make in reports about this research 
(we would not use your name)?                   [       ]      [       ]    
 
Participant signature: ………………………………  Date: ……………… 
 
 
Name in Block Letters:  ……………………………           
 
 
 
Researcher signature:  ………………………………….  Date: ……………… 
 
 
Name in Block Letters:  …………………………… 
 
 
This research project has been approved by NHS GG&C Ethics Committee 
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Appendix 2.4: Narrative Interview for Compassion and Recovery  
 
 
1) - Introduction 
 
Today I would like to give you an opportunity to talk about how you respond at times when 
you are feeling stressed or upset.  
 
For example, I'm thinking here of things like moving house, money worries, or social 
occasions. However, I'm most interested in examples that are relevant to your current 
circumstances.  I would also like to hear about your sources of support at such times, how 
you feel when you are upset, and how you cope with such situations.  
 
To help me get a picture of your own circumstances I would first like to spend some time 
getting an idea of the people and relationships that are important to you. Then we would like 
you to tell us about some specific experiences you have had where you have felt stressed or 
upset.   
 
I understand that some of the experiences that I asking you about may be difficult for you to 
discuss. Therefore you do not have to tell me about the most distressing experience you 
have had, but I would like to hear an experience that you feel has been stressful, upsetting 
or challenging.  
 
Before we start, are there any questions you have about today? 
 
2) - Social support network 
First of all, I would like to know a little more about who the important people in your 
life are at the moment. I'm going to write these down as you say them. 
 
{After completing list} 
 
 
2.1)  To help keep me understand how much these people are involved in your life I am 
going to map what you've told me out on this piece of paper {Introduce Social 
Network Diagram}. First I'm going to write your name in the centre of the page, then I 
would like to take each of the people we have talked about and write their name on 
the page, with an arrow pointing to you, the shorter the length of the arrow from them 
to you the closer you feel your relationship. Let’s start with Person 1… 
 
 
2.2)  Out of the people we've just talked about who would you say you have the closest 
relationship with? 
 
2.3) Why would you say that you are closest to that person? 
 
3) Everyone copes with stress in different ways.  What do you do when you feel 
stressed or upset? 
 
3.1) Does anything in particular help when you are feeling stressed? 
 
3.2) What do you do if your solution to the problem does not work? 
 
3.3) Does anyone else ever help you when you have difficulties? 
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3.4) Would you ask anyone else for help of you needed it? 
 
3.5)  Sometimes things can just be so hard that we avoid them – have you ever done that? 
 
3.6) Thinking of the people on the diagram, would you go to any of them for support? 
 
4) - Recent stressor/compassion frame  
 
Thank you for explaining that to me. Now, I'm going to ask you about how you cope 
with stress. I would like you to tell me about a specific experience or thing that 
happened to you in the last month or so. Just something that sticks out in your mind.  
 
I would like you to tell me about a time when you had to use your coping skills. There 
are a few questions I would like to ask you about this, but first I would like you, in 
your own words, to give me an idea of what happened: 
 
If general response given - That’s a good general description, but I’m wondering if there was 
a particular time that happened? 
 
If no example offered - The experiences I am thinking about are things like moving house, 
financial worries, or concerns about going out. Doe anything come to mind from those 
examples? 
 
4.1) Follow-up probes to establish context of autobiographical memory: 
 
4.1.1)  What happened next? 
 
4.1.2) What did you do? 
 
4.1.3) Who was involved? 
 
4.1.4) What were you thinking at the time? 
 
4.1.5) How did you feel at the time?  
 
4.1.6) Did you look to any of the people on the diagram for support?  
 
 
4.2a - If social support figure mentioned 
 
4.2.1)  You said Person X was involved, How did Person X respond to you during the 
experience we've talked about?  
 
4.2.2) At the time, did you feel supported by them?  
In what way? 
 
4.2.3)  How did you respond to them doing/saying that? 
 
4.2.4) What do you think was going through Person X’s mind at that time? 
How do you think they might have been feeling? 
 
4.2.5)  Do you have any ideas about what made them feel that way? 
…Or what made them behave in that way? 
 
4.2.6)  Reflecting on this now, do you feel they were supportive of you?  
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4.2.7)  Do you think they realised the effect that response had on you? 
 
4.2.8) Looking back, is there a different way Person X could have approached or supported 
you during this situation? 
 
4.2.9)  Is there anything that you would have liked them to do to help? 
 
4.2.10) Thinking about the support you got from person X. Is that the same for all situations?  
 If not, why?  
 
4.2.11) Would there be anyone else that you looked to for support? 
 What did they do? 
 
4.2.11) I’m just wondering, how do you think someone else would deal with the situation 
you’ve just described…?  
 
4.2.12) What sort of things would you say to a friend, if they went through a similar 
experience but acted differently to you?  
 
4.2.13) How do you think this experience has influenced your life? 
 
 
4.2.b - If no support figures mentioned 
I'm just curious, did you talk to any of the people we've talked about on your diagram about 
this experience? 
 
Then as for (4.2.1) 
 
{If none offered} 
 
Thinking about that experience, is there anyone whom you would have liked to have been 
supported by? 
 
Then as for (4.2.1) 
 
 
5 - Summing up 
We've talked about quite a lot today, but is there anything you feel you have learned 
from the  experiences we've talked about? 
 
5.1  What are your hopes for the future?  
 
-------------------------------------------------END--------------------------------------------------------- 
 
(Throughout Interview) General Prompts: 
 
I’m interested to know more about that, can you tell me a bit more? 
 
Could you give me an example of feeling/doing/thinking that? 
 
I’m wondering what makes you say that? 
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Appendix 2.5: MAS-R Rating Scale Scoring Sheet 
 
MAS – R 2009 Not 
en
ga
ge
d 
Sc
ar
c
e 
M
in
im
al
 
 
M
o
de
ra
te
 
G
o
o
d 
So
ph
is
ti-
ca
te
d 
Ba
s
i
c 
re
q.
 BR The person recognizes to possess mental functions and represents 
her/himself as an individual who thinks and feels in an independent 
manner. 
N.E. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
m
o
n
ito
rin
g 
UM1 COGNITIVE IDENTIFICATION the person is able to distinguish and 
differentiate his/her own cognitive operations (e.g. remembering, imagining, 
having fantasies, dreaming, desiring, deciding, foreseeing and thinking). 
N.E. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
UM2 EMOTIONAL IDENTIFICATION the person is able to define, distinguish 
and name his/her own emotional states. 
N.E. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
UM3 RELATING VARIABLES   the person identifies and describes the 
relations among the aspects of subjective experience: i.e. causes for his own 
thought or emotion or behaviour, the effects of a thought or an emotion, the 
inner or social factors influencing own actions. 
N.E. 
 
1 
 
2 
 
3 
  
4 
 
5 
 
di
ffe
re
n
tia
tio
n
 
UM4 the person recognises his/her thought as subjective, his/her opinions and 
forecasts as hypotheses, considering the possibility they change as contexts 
change and time passes (including the ability to take a critical distance from 
own beliefs). Thoughts are not considered reality per se and ideas or wishes 
cannot influence directly events or change reality.  
N.E. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
UM5 the person distinguishes among belief, fantasy, dreams, memories and 
forecasts. Reality judgement is intact and the person is aware of when and 
where a scene is taking place. 
N.E. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
in
te
gr
at
io
n
 
UM6 the person is able to describe in a coherent narrative the cognitive and 
emotional aspects of his/her own states of mind and how they were changing 
during time, grasping links and causal relations that promoted changes. 
N.E. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
UM7 the person describes the cognitive and emotional aspects of his/her own 
different states of mind integrating the multiplicity – and possible contradictions 
– of representations in a consistent narrative. 
N.E. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
m
o
n
ito
rin
g 
UOM1 COGNITIVE IDENTIFICATION   the person is able to define and 
distinguish the others’ cognitive operations (e.g. remembering, imagining, 
having fantasies, dreaming, desiring, deciding, foreseeing and thinking). 
N.E. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
UOM2 EMOTIONAL IDENTIFICATION   the person is able to define and 
distinguish the others’ emotional states. 
N.E. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
UOM3 RELATING VARIABLES  the person is able to make hypotheses about 
the links explaining the relationships among other’s thoughts, emotions and 
overt behaviour e.g. the causes behind a thought, emotion or type of behaviour  
N.E. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
D
ec en
 
tr
at
i
o
n
 
D The person is able to describe the other’s mental state forming hypothesis 
which are independent from his/her own perspective and from his/her own 
involvement in the relationship. 
N.E. 
  
1 
 
2 
 
3 
 
4 
 
5 
 
Ba
si
c
 
re
q.
 
M1  The person discusses his own behaviour and psychological processes and 
states not as simple matter-of-fact data but as tasks to be done and problems 
to be solved, defining the terms of the problem in a plausible way and adopting 
an active problem-solving stance 
N.E. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
1s
t l
ev
el
 
s
tr
at
.
 
M2 the person tries to act on problematic states modifying the bodily state. N.E. 
 
1 
 
2 
 
3 
 
4 
  
5 
 
M3 the person tries to avoid the eliciting conditions of a problematic state 
and/or uses the relational context as a support. N.E. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
2n
d 
le
v
e
l 
st
ra
t. 
M4 the person deals with the problem voluntarily imposing or inhibiting a 
behaviour on him/herself. 
N.E. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
M5 the person deals with the problem through the regulation and management 
of his/her mental states, distracting her/himself from ideas and emotions 
causing suffering. 
N.E. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
3r
d 
le
v
el
 
st
ra
t. M6 the person deals with the problem operating on underpinning beliefs and evaluations and/or by using his/her general knowledge on his/her own mental 
functioning. 
N.E. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
M7 The person faces the interpersonal dimension of the problem using his/her 
own knowledge of other people’s mental functioning. 
N.E. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
M8 The person faces the problem accepting in a mature way his/her own limits 
in changing his/her own inner states and influencing events.  
N.E. 
 
1 
 
2 
 
3 
 
4 
 
5 
 
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Appendix 2.6: Participant Debriefing Sheet 
 
 
 
 
 
Debriefing Sheet 
 
 
Thank-you for agreeing to take part in this study.  Your data is will now be 
anonymised and put together with other data so we can look at differences in the 
way people think about themselves and others. 
 
We do not expect that participating in this research will have a negative effect on 
anyone.  However, if you have felt upset or worried by anything raised from your 
participation in this study, please discuss this with your key worker or a member of 
your clinical team.  
 
We remind you that you can withdraw your consent to participation in this study at 
any time without giving a reason.  This will not affect your current or future care or 
treatment.  Contact details are provided below.   
 
Thank-you once again for your time. 
 
 
 
Laura Mitchell                    Prof Andrew Gumley 
Trainee Clinical Psychologist                Psychological Medicine 
[ADDRESS]                  [ADDRESS] 
Email xxxxxxx@student.gla.ac.uk                             Telephone number: (0141) xxx xxxx 
Telephone number:  (0141) xxx xxxx    
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Appendix 2.7: Letter of Ethical Approval 
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Appendix 2.8: Letter of R&D approval 
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Appendix 2.9: Major Research Project Proposal 
 
 
Major Research Project Proposal 
 
An investigation into metacognition and violence in psychosis 
 
 
 
 
 
 
Matriculation number:  0805282 
 
Date of submission: 23rd July 2010 
 
Version number: 4 
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Research Question 
 
What patterns of metacognitive ability exist in violent offenders with schizophrenia in a 
forensic setting?  An exploration of personal narratives.  
 
 
Introduction 
 
In a recent longitudinal study, Fazel, Långström, Hjern, Grann and Lichtenstein (2009) 
reported that, although the statistical probability was extremely low, a diagnosis of 
schizophrenia was nevertheless associated with an increased risk of perpetrating violent 
crime.  Although no one single variable explains violence in individuals with a schizophrenia 
spectrum disorder, and violence is relatively uncommon, it can be problematic (Swanson et 
al., 2006).  For example, if we turn our attention towards forensic mental health populations, 
although the types of offences committed are mixed, nearly half of patients are detained for 
violent or sexual offences (Rutherford & Duggan, 2008). 
 
In recent years the focus of care in forensic mental health services has shifted from looking 
solely at the assessment and management of risk to using this to inform rehabilitation and 
long-term community management practices (Lindqvist & Skipworth, 2000).  Beyond this 
some approaches have begun to look past the risk-need models of rehabilitation and 
towards positive psychology approaches (e.g. Good Lives Model, Ward & Brown, 2004).  
However, despite these attempts to identify effective ways of rehabilitating mentally 
disordered offenders (MDOs) (and ultimately reducing recidivism rates), there is still little in 
the way of evidenced-based treatments for people with a history of violence and 
schizophrenia.   
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At the turn of the millennium Bloom, Mueser and Müller-Isberner (2000) concluded that 
although as yet there was a lack of specific evidence-based literature on the treatment of 
violence amongst MDOs (including those with schizophrenia), the required components had 
been identified that could produce an effective approach to treatment.  However, more than 
a decade later, and it appears as though we are still searching for an effective treatment 
approach.  Medication is common in the treatment of violence in patients with schizophrenia, 
although findings on effectiveness are inconsistent, due in part to the methodological 
limitations of studies (Volavka & Citrome, 2008).  In terms of psychological treatments for 
violence amongst MDOs, the evidence base is even less.  In a recent study, Haddock et al 
(2009) carried out a randomised controlled trial to assess the effectiveness of cognitive-
behavioural therapy (CBT) on violence, anger and psychosis in people with a diagnosis of 
schizophrenia who had a history of violence.  Compared to a treatment as usual group and 
social activity therapy group, those in the CBT group showed little advantage in terms of a 
reduction in violence or aggression.  For example, no significant difference was found 
between groups for the number of people who had shown no violence or aggression vs. the 
number who had shown one or more incidents, either during treatment or at 6- or 12-month 
follow-up. 
 
Following the difficulty in identifying successful treatments for violence amongst MDOs with 
schizophrenia, one might begin to question what it is about this population that makes this a 
difficult task.  Although undoubtedly a complex issue, one area to consider might be that 
suggested by Peter Fonagy (2003).  He argued that there was a relationship between one’s 
ability to ‘mentalize’ and violence.  Specifically, when mentalization abilities are 
compromised, there follows an increased propensity for violence.  Mentalization (or 
metacognitive functioning), has been shown to be impaired in people with schizophrenia 
(Frith, 1992).   
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‘Metacognition’ describes the skill humans acquire that enables them to think about thinking 
(Semerari et al., 2003).  This general ability allows us to not only represent our own mental 
states and those of others, but allows us to make sense of our predicaments and understand 
the intentions of others, as well as being able to adapt to new and challenging situations 
(Frith, 1992).  It is argued that metacognitive capabilities are possible through their 
comprising several semi-independent faculties that work both independently and together 
(Dimaggio, Lysaker, Carcione, Nicolò & Semerari, 2008).    Within the literature other terms 
are often used interchangeably with metacognition – specifically ‘Theory of Mind’ (ToM) and 
‘Mentalization’ – which describe similar phenomena.  ToM refers to the ability to represent 
one’s own and others’ mental states, usually in relation to thoughts and beliefs (Brüne, 
2005).  However, although this describes a crucial part of metacognition, it likely only 
represents one part of a wider system that allows one to think about thinking (Lysaker et al., 
2009).  Mentalization is described as the capacity to view mental states as independent 
from, but able to potentially influence, actions.  However, this concept has evolved from the 
attachment literature, in comparison to metacognition’s cognitive origins (Bateman & 
Fonagy, 2004).  
 
Although the relationship between metacognition and violence in schizophrenia has not 
been investigated, metacognition in schizophrenia has been considered more generally.  It is 
thought the differences reported in metacognitive functioning underpin many of the positive 
and negative symptoms commonly associated with schizophrenia spectrum disorders, 
including delusions and hallucinations (Frith, 1992).  Traditionally, research in this area has 
tested ToM abilities using adaptations of psychological tests commonly used with young 
children.  Further to this, research has also measured “intentionality” using short stories, and 
story-boarding tasks, or tests of first- and second-order ToM through comprehension of 
irony, faux pax and metaphor.  The findings from this laboratory-based research indicate a 
specific deficit in ToM abilities in schizophrenia (Brüne, 2005).  However, although 
improvements in methodology have been made over the years, there is still limited 
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generalisability of experimental laboratory tasks to real-life situations, particularly in persons 
with psychiatric disorders (Simpson, Done & Vallée-Tourangean, 1998).   
 
Lysaker and colleagues have investigated metacognitive deficits in people with 
schizophrenia, specifically measuring difficulties this group has with capturing their own 
thoughts and the thoughts of others, by using narratives of self and illness (Lysaker et al., 
2005; Lysaker, Dimaggio, Buck, Carcione & Nicolò, 2007; Lysaker et al., 2008; Lysaker et 
al., 2009).  They argue narratives provide a way of assessing metacognition from different 
perspectives within a real-world context, which provides an alternative to the analogous 
laboratory tasks (Lysaker et al., 2005).   
 
From their research using the narratives of people with schizophrenia, Lysaker et al, (2007) 
reported metacognitive deficits were apparent in the majority of their sample.  Specifically 
85% of their participants had difficulty being able to identify and differentiate their own 
emotions and/or being able to view the world as a place where other individuals with their 
own unique thoughts, feelings and perspectives co-exist.  Furthermore they suggested 
different metacognitive profiles appear to be associated with different neurocognitive 
correlates.  It is therefore possible that metacognitive deficits observed in people with 
schizophrenia may be a cause or function of neurocognitive impairments, which acts as a 
barrier to functioning within this clinical population.  This hypothesis was further supported by 
the finding that different areas of metacognition were influenced by (or possibly themselves 
influenced) different domains of executive functioning (Lysaker et al., 2008).  Although the 
cross-sectional design of this study makes direction of causality difficult to discern, were 
deficits in certain areas of executive functioning to influence metacognition, these results 
explain some of the interpersonal difficulties, and positive and negative symptoms, people 
with schizophrenia spectrum disorders experience.  For example, deficits in inhibitory 
processes may make it difficult for one to switch from being preoccupied with self-related 
thoughts to thinking about a situation from the perspective of another person.  This may 
Page | 107  
 
have implications for source monitoring, which could perhaps explain the experience of 
delusions.   
 
Given this body of work that has looked at metacognitive problems in people with 
schizophrenia, and the difficulty reported with treating violence amongst forensic populations 
with this diagnosis, it seems timely to begin to explore this further.  Although exploring the 
presence of a link between metacognition and violence would be complex and difficult to 
discern, a more general investigation into the pattern of metacognitive problems could be 
helpful.  Exploring this matter in people with schizophrenia with a history of interpersonal 
violence (IV) who are currently being treated within the forensic mental health system could 
allow us more insight into how better to approach the rehabilitative needs of this population.  
For example, problems identified may be a vulnerability factor to the development of further 
interpersonal difficulties, in terms of interpreting and understanding mental states.  The 
proposed research aims to do this by exploring metacognitive profiles, evidenced through 
narratives of self, in individuals with schizophrenia.  Metacognitive abilities of those who 
have a history of IV and being treated by forensic services will be compared to a community 
sample with schizophrenia who have no history of IV. 
 
 
Aims 
 
This is an exploratory study that aims to investigate the profile of metacognitive abilities in 
individuals in forensic settings with schizophrenia who have a history of IV.  Findings will be 
compared to a control group of a community sample of people with schizophrenia who do 
not have a history of IV. 
 
Where differences between the two groups are present, effect sizes will be calculated in 
order to inform power calculations for future research.   
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Hypotheses 
 
H1: Metacognitive deficits will exist in both the experimental group and the control group. 
 
H2: The experimental group will show a lesser degree of metacognitive functioning relative to 
the control group.  
 
 
Plan of Investigation 
 
Participants 
 
Experimental group:  
15 male NHS forensic patients with a primary diagnosis of schizophrenia, or similar, who 
have a history of IV.   
 
Control group:  
15 male NHS community patients with a primary diagnosis of schizophrenia, or similar.  
Participants will have no history of IV. 
   
Inclusion and Exclusion Criteria 
 
Experimental Group: 
To be included in the study, participants must be age 18-64 and have a primary diagnosis of 
schizophrenia or similar. Diagnosis will be confirmed by information from patient’s files.  This 
will be in the form of a DSM-IV or an ICD-10 diagnostic code.  Participants with a secondary 
diagnosis of a mood disorder and/or personality disorder will also be included.  The definition 
of a ‘history of IV’ will be taken from the HCR-20: actual, threatened or attempted harm 
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towards others.  This can be verbal or physical and may include fire-raising if the intent was 
to cause physical or psychological harm to others.  The IV will relate to an index offence and 
an assessment of risk must suggest participants would be at risk of further interpersonal 
violence, without the protective environment of a secure setting.  Evidence of IV will be 
judged from HCR-20 reports in the participant’s file, or other file information, for example a 
Scottish Criminal Records Office (SCRO) pro-forma, which details criminal convictions.  
Participants will also be under the care of NHS forensic services.   
 
Those who are acutely psychotic will be excluded from participating in the study.  Further 
exclusions include people who have an identified Intellectual Disability or Autistic Spectrum 
Disorder.  In addition, people who have a history of brain injury, originating from organic 
disorders or substance misuse, will not be able to participate in the study.  A final exclusion 
criteria purports people will be unable to participate if they do not have English as their first 
language, given the use of narrative data. 
 
Control Group: 
To be included in the study, participants must be age 18-64 and have a primary diagnosis of 
schizophrenia or similar.  Diagnosis will be confirmed by information from patient’s files.  
This will be in the form of a DSM-IV or an ICD-10 diagnostic code.  Participants with a 
secondary diagnosis of a mood disorder and/or personality disorder will also be included.  
Participants will also be under the care of NHS community mental health teams.   
 
Patients with a history of IV will be excluded from participating in the study.  Further 
exclusions, as detailed for the experimental group, also apply. 
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Recruitment Procedures 
 
Experimental group participants will be recruited from services within the NHS Greater 
Glasgow & Clyde Forensic Mental Health and Learning Disabilities Directorate and from 
forensic services within NHS Scotland.  Recruitment will first target the Rowanbank Clinic, a 
74-bed medium-secure forensic mental health unit.  Further to this the trainee will target 
forensic wards at Leverndale Hospital, and out-patients at the Douglas Inch Centre.  The 
trainee will also recruit from the Orchard Clinic, Edinburgh.   
 
The trainee will initially liaise with the responsible medical officers (RMOs) at each site, who 
will be asked to identify patients suitable for participation in the study.  The trainee will then 
approach in person the patients identified and provide them with information about the study.  
Patients will be given a minimum of 48 hours to study the participant information, and given 
the opportunity to ask the trainee and/or their RMO questions, before consent to participation 
is sought.    
 
Control group participants will be recruited from Community Mental Health Services within 
Greater Glasgow & Clyde.  This will be part of a linked project supervised by Prof Andrew 
Gumley. 
 
Measures 
 
Brief Symptom Inventory (BSI) 
The BSI (Derogatis, 1975) is a self-report measure that aims to identify psychological 
symptoms of clinical significance.  The 53-item measure looks at nine symptom classes 
including depression, anxiety and paranoid ideation.  Further to this it can yield overall 
measures of current and past symptom levels, symptom intensity and total number of 
symptoms.   
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HCR-20 
The HCR-20 (Webster, Douglas, Eaves & Hart, 1997) is a structured clinical assessment 
tool, which aides clinical judgement on risk of future interpersonal violence.  It comprises 20 
items, which are classified under 3 domains: historical, clinical and risk-management.  Each 
item in the 3 domains can be scored 0-2 (0 = no evidence; 1 = partially present; 2 = definite 
evidence) accordingly.  Although in clinical practice the HCR-20 is used within a qualitative 
framework, it can be used quantitatively for research purposes.   
 
Inventory of Interpersonal Problems – Short Circumplex Form (IIP-SC) 
The IIP-SC (Soldz, Budman, Demby & Merry, 1995) is a 32-item measure, which looks at a 
person’s level of interpersonal functioning.  It can be used to help differentiate interpersonal 
from non-interpersonal sources of distress that an individual might be experiencing.  It has 
been developed from the 127-item IIP to make it suitable for research purposes.  
 
Metacognitive Assessment Scale (MAS):  
The MAS (Carcione, Dimaggio, Conti, Fiore, Nicolò & Semerari, in press) is a tool that can 
be applied to narratives to measure metacognitive abilities.  In addition to looking at 
metacognition as a whole, it can also provide a measure of the sub-functions of 
metacognition.  To do this the MAS uses 3 sub-scales (Understanding of One’s Own Mind, 
Understanding of Other’s Mind, and Mastery), which each contain various sub-functions, to 
build up a profile of an individual’s metacognitive abilities.  For each sub-function points can 
be awarded by the rater according to the level of metacognitive skills evident in the narrative.  
These can be summed to yield a total score of metacognitive ability.   
 
The Positive and Negative Syndrome Scale (PANSS): 
The PANSS (Kay, Fiszbein & Opler, 1987) is a scale comprising 30 items that allows ratings 
to be made on a range of symptoms associated with severe mental health problems.  
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Ratings are made along a 7-point scale.  The scale is divided into 4 sub-scales that allow for 
separate analysis of positive and negative symptoms.   
 
Relational Compassion Scale (RCS) 
The RCS is a 40-item questionnaire, which assesses relational appraisal of compassionate 
self-other relating on a 4-point Likert scale (0-3).  It is a self-report measure, and has been 
shown to have good internal reliability and construct validity (Hacker, 2008).   
 
Relationship Scales Questionnaire (RSQ): 
The RSQ (Griffin & Bartholomew, 1994) is a 30-item self-report measure drawn from other 
measures of attachment.  Participants are asked to rate how closely statements match their 
personal style in close relationships.  Statements are representative of different attachment 
patterns.  Scores can be produced to reflect each participant’s alignment with the different 
attachment styles.  
 
Design 
 
The proposed research is part of a larger collaborative study under the supervision of Prof 
Andrew Gumley.  Proposals submitted by Dr Angus MacBeth and Ms Elizabeth Reilly will be 
combined with this one to form a single protocol, which will be submitted to ethics. 
  
The research proposed in this submission will use a 2-group between and within groups 
design.  The independent variable under control is history of interpersonal violence amongst 
people with a diagnosis of schizophrenia.  The dependent variable being measured is 
metacognitive abilities. 
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Research Procedures 
 
Following recruitment (where potential participants are given verbal and written information 
about the research), the trainee will meet with participants in the experimental group on 2 
occasions, at least 48 hours after initial contact.  During the first of these meetings the 
trainee will gain formal consent for participation in the study, and access to patient files.  If 
this is granted the trainee will then begin a period of engagement, before conducting a semi-
structured interview to generate the narrative data to be analysed.  To do this the interview 
will allow participants the opportunity to “think about their own thinking, the thinking of others 
and the problems they are presented, without posing direct problems to be solved.” (Lysaker 
et al., 2005, p.65).  The interview will take approximately 1 hour to complete.   
 
Between the first and second meeting, the trainee will gain access to participant files to 
record demographic information.  This will include age, diagnostic codes (for both primary 
and secondary diagnoses), number of years since primary diagnosis was given, and 
treatment history (e.g. therapeutic programmes completed).  File information will also be 
used to score the HCR-20 and record details of IV. 
 
At the second meeting the trainee will clarify any anomalies identified in the file information 
with the participant.  Following this, participants will be given the self-report measures with 
instructions on how to complete them.  Self-report measures will then be collected and the 
participant will be fully debriefed.  This will allow for plenty of opportunity for the participant to 
ask the trainee questions. 
 
Interviews will be transcribed and coded using the MAS to produce quantitative data on 
metacognitive abilities.  Half the transcribed interviews from the control group will also be 
coded by the trainee using the MAS.  The remaining control group transcribed interviews will 
be coded using the MAS by the trainee’s colleague, Ms Elizabeth Reilly.  All research data 
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will then be entered into a Statistical Package for Social Sciences (SPSS) database and 
analysed using the appropriate statistics to answer the research question.   
 
Justification of Sample Size 
 
This is an exploratory study, as there is little research available that addresses the aims of 
the proposed research.  Therefore it is not possible to perform a power calculation based on 
similar research in order to produce an estimate of required sample size.  In terms of the 
available resources, including time required for data collection, transcription, coding, and 
analysis, it is predicted this allows for n=15 for the experimental and control groups 
(therefore total n=30).  Where differences do exist, Table 1 shows the power (1-β) this 
sample size would have, for different effect sizes, for both parametric and non-parametric 
tests of difference. 
 
Table 1: Estimates of power (1-β) as a function of effect size and distribution of data 
 
Effect Size (Cohen’s d) 
Test of difference used 
Parametric Non-Parametric 
Small (0.2) 0.13 0.13 
Medium (0.5) 0.23 0.37 
Large (0.8) 0.43 0.67 
 
Post-hoc effect size calculations will be done where possible to inform future studies in this 
area. 
   
Settings and Equipment 
 
The trainee will first conduct research with participants at the Rowanbank Clinic, Glasgow.  If 
recruitment from out with this site is required, participants will be seen at the site from which 
they were recruited.  This will be a NHS hospital or out-patient clinic. 
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To complete the research whilst adhering to NHS data protection policies, the researcher will 
require access to a digital voice recorder, an encrypted laptop, and an on-site filing cabinet 
with a lock.   
 
Data and Analysis 
 
Data will exist in several forms.  The interviews will be stored on a digital voice recorder.  
This information will then be transcribed by the researcher and stored in a secure format on 
an encrypted laptop.  Further information will be collected from questionnaires completed by 
participants, and from participants’ mental health files. This data will be stored securely on 
site premises or entered onto a database on an encrypted laptop.      
 
Transcribed interviews will be coded using the MAS.  It is only possible to use this tool after 
specific training and supervision has been given.  Therefore this process will be closely 
supervised by Prof Andrew Gumley, which will require him to have access to the data via the 
University of Glasgow computer network.  Prof Gumley will check all the codings produced 
by the researcher to ensure accuracy and consistency.  This will also provide inter-rater 
reliability data.  Coded data from the MAS will then be statistically analysed using the 
appropriate parametric and/or non-parametric tests that will test for differences between the 
experimental and control groups.  Data from the self-report measures and participant files 
will be analysed using the appropriate parametric and/or non-parametric tests to provide 
supplementary between- and within-group information.  These will help to explore other 
variables of interest.  
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Health and Safety Issues 
 
Researcher Safety Issues 
 
As the research is mainly being conducted within a medium-secure environment, appropriate 
health and safety considerations will apply.  All research will be completed on NHS premises 
during working hours when other clinicians are present. 
 
Participant Safety Issues 
 
Although ethical approval will be sought before beginning data collection, some aspects of 
the process may be quite emotive.  In particular, asking participants during the interview to 
reflect on a difficult situation may evoke an emotional response.  However, participants will 
be made aware that they can withdraw from the study at any point and will be fully debriefed 
after the interview.  Furthermore, they will be encouraged to discuss any difficult issues 
participating in the research has raised for them with the trainee or a member of their clinical 
team. 
 
Ethical Issues 
 
Usual ethical research considerations will apply.  However, due to the nature of the research 
setting, and the participants, obtaining ethical consent may take slightly longer than other 
non-clinical research proposals.  Therefore ethics applications will need to be considered 
early on in the research process. 
 
This research requires access to sensitive information on acts of IV committed by people 
with schizophrenia.  This information will be obtained from patient files.  Participants will be 
asked to give fully informed consent for access to these files and will have time to think 
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about the matter and ask questions.  They will also be made aware that they can withdraw 
consent at any point in the research process.  
   
 
Financial Issues 
 
Please see finance form submitted with the proposal. 
 
 
Timetable 
 
April 2010: Submit MRP proposal 
 
August 2010: Submit ethics proposal 
 
September 2010: Start participant recruitment 
 
September 2010 – February 2011: Interview participants and collect further data from mental 
health files  
 
October 2010 – March 2011: Data transcription and coding 
 
April 2011: Data analysis 
 
May 2011 – July 2011: Write-up and submission 
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